BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
578907	CCOC(=O)c1nc2cccnn2c1I	InChI=1S/C9H8IN3O2/c1-2-15-9(14)7-8(10)13-6(12-7)4-3-5-11-13/h3-5H,2H2,1H3	MPPQGDQFACBNCH-UHFFFAOYSA-N	302432	BDBM302435::US9598421, Example 1::Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 38.6							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302432	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302432&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863061	381751168							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578908	CCOC(=O)c1nc2cccnn2c1I	InChI=1S/C9H8IN3O2/c1-2-15-9(14)7-8(10)13-6(12-7)4-3-5-11-13/h3-5H,2H2,1H3	MPPQGDQFACBNCH-UHFFFAOYSA-N	302432	BDBM302435::US9598421, Example 1::Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 35.5							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302432	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302432&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863061	381751168							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578909	CCOC(=O)c1nc2cccnn2c1I	InChI=1S/C9H8IN3O2/c1-2-15-9(14)7-8(10)13-6(12-7)4-3-5-11-13/h3-5H,2H2,1H3	MPPQGDQFACBNCH-UHFFFAOYSA-N	302432	BDBM302435::US9598421, Example 1::Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 130							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302432	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302432&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863061	381751168							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578910	CCOC(=O)c1nc2cccnn2c1I	InChI=1S/C9H8IN3O2/c1-2-15-9(14)7-8(10)13-6(12-7)4-3-5-11-13/h3-5H,2H2,1H3	MPPQGDQFACBNCH-UHFFFAOYSA-N	302432	BDBM302435::US9598421, Example 1::Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 10300							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302432	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302432&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863061	381751168							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578911	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22)	YOCIPGYKDZCTFU-UHFFFAOYSA-N	285529	US10077269, Example 2::3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US9598421, Example 2::US10669279, Example 2	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 10.7							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863067	378169168							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578912	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22)	YOCIPGYKDZCTFU-UHFFFAOYSA-N	285529	US10077269, Example 2::3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US9598421, Example 2::US10669279, Example 2	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 17.7							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863067	378169168							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578913	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22)	YOCIPGYKDZCTFU-UHFFFAOYSA-N	285529	US10077269, Example 2::3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US9598421, Example 2::US10669279, Example 2	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 27.9							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863067	378169168							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578914	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-5-3-10(4-6-11)15-14(16(22)19-12-7-8-12)20-13-2-1-9-18-21(13)15/h1-6,9,12H,7-8H2,(H,19,22)	YOCIPGYKDZCTFU-UHFFFAOYSA-N	285529	US10077269, Example 2::3-(4-Chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (2)::US9598421, Example 2::US10669279, Example 2	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 4340							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285529	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285529&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863067	378169168							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578915	COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3	SCHCQOLPISHKOS-UHFFFAOYSA-N	285530	US10077269, Example 3::Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US9598421, Example 3::US10669279, Example 3	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 12.7							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863063	378169169							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578916	COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3	SCHCQOLPISHKOS-UHFFFAOYSA-N	285530	US10077269, Example 3::Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US9598421, Example 3::US10669279, Example 3	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 29.1							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863063	378169169							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578917	COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3	SCHCQOLPISHKOS-UHFFFAOYSA-N	285530	US10077269, Example 3::Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US9598421, Example 3::US10669279, Example 3	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 51.9							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863063	378169169							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578918	COc1c(F)cc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H14F2N4O2/c1-25-16-11(18)8-10(9-12(16)19)15-14(17(24)22-6-3-7-22)21-13-4-2-5-20-23(13)15/h2,4-5,8-9H,3,6-7H2,1H3	SCHCQOLPISHKOS-UHFFFAOYSA-N	285530	US10077269, Example 3::Azetidin-1-yl[3-(3,5-difluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (3)::US9598421, Example 3::US10669279, Example 3	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2410							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285530	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285530&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863063	378169169							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578919	CCOC(=O)c1nc2cccnn2c1I	InChI=1S/C9H8IN3O2/c1-2-15-9(14)7-8(10)13-6(12-7)4-3-5-11-13/h3-5H,2H2,1H3	MPPQGDQFACBNCH-UHFFFAOYSA-N	302432	BDBM302435::US9598421, Example 1::Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 187							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302432	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302432&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863061	381751168							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578920	CCOC(=O)c1nc2cccnn2c1I	InChI=1S/C9H8IN3O2/c1-2-15-9(14)7-8(10)13-6(12-7)4-3-5-11-13/h3-5H,2H2,1H3	MPPQGDQFACBNCH-UHFFFAOYSA-N	302432	BDBM302435::US9598421, Example 1::Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 380							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302432	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302432&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863061	381751168							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578921	CCOC(=O)c1nc2cccnn2c1I	InChI=1S/C9H8IN3O2/c1-2-15-9(14)7-8(10)13-6(12-7)4-3-5-11-13/h3-5H,2H2,1H3	MPPQGDQFACBNCH-UHFFFAOYSA-N	302432	BDBM302435::US9598421, Example 1::Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 561							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302432	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302432&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863061	381751168							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578922	CCOC(=O)c1nc2cccnn2c1I	InChI=1S/C9H8IN3O2/c1-2-15-9(14)7-8(10)13-6(12-7)4-3-5-11-13/h3-5H,2H2,1H3	MPPQGDQFACBNCH-UHFFFAOYSA-N	302432	BDBM302435::US9598421, Example 1::Azetidin-1-yl[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone (1)	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>27100							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302432	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302432&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863061	381751168							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578923	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N	InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23)	YDADFGXXCHDXFC-UHFFFAOYSA-N	285532	US10077269, Example 5::3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US9598421, Example 5::US10669279, Example 5	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 40.2							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863059	378169171							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578924	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N	InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23)	YDADFGXXCHDXFC-UHFFFAOYSA-N	285532	US10077269, Example 5::3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US9598421, Example 5::US10669279, Example 5	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 89.5							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863059	378169171							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578925	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N	InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23)	YDADFGXXCHDXFC-UHFFFAOYSA-N	285532	US10077269, Example 5::3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US9598421, Example 5::US10669279, Example 5	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 208							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863059	378169171							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578926	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc(nc1)C#N	InChI=1S/C16H12N6O/c17-8-12-4-3-10(9-18-12)15-14(16(23)20-11-5-6-11)21-13-2-1-7-19-22(13)15/h1-4,7,9,11H,5-6H2,(H,20,23)	YDADFGXXCHDXFC-UHFFFAOYSA-N	285532	US10077269, Example 5::3-(6-Cyanopyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (5)::US9598421, Example 5::US10669279, Example 5	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>26600							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285532	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285532&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863059	378169171							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578927	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24)	KZFDLYSKEWBCTB-UHFFFAOYSA-N	285533	US10077269, Example 6::N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US9598421, Example 6::US10669279, Example 6	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 64.4							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863057	378169172							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578928	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24)	KZFDLYSKEWBCTB-UHFFFAOYSA-N	285533	US10077269, Example 6::N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US9598421, Example 6::US10669279, Example 6	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 49.3							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863057	378169172							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578929	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24)	KZFDLYSKEWBCTB-UHFFFAOYSA-N	285533	US10077269, Example 6::N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US9598421, Example 6::US10669279, Example 6	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 326							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863057	378169172							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578930	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-4-5-11)14-15(23-13(21-14)2-1-7-18-23)10-3-6-12-17-9-19-22(12)8-10/h1-3,6-9,11H,4-5H2,(H,20,24)	KZFDLYSKEWBCTB-UHFFFAOYSA-N	285533	US10077269, Example 6::N-Cyclopropyl-3-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide (6)::US9598421, Example 6::US10669279, Example 6	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 4890							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285533	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285533&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863057	378169172							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578931	Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1	InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26)	LSCITVBMOOTYOS-UHFFFAOYSA-N	285534	US10077269, Example 7::3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US9598421, Example 7::US10669279, Example 7	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 2.77							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863065	378169173							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578932	Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1	InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26)	LSCITVBMOOTYOS-UHFFFAOYSA-N	285534	US10077269, Example 7::3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US9598421, Example 7::US10669279, Example 7	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		<1.89							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863065	378169173							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578933	Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1	InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26)	LSCITVBMOOTYOS-UHFFFAOYSA-N	285534	US10077269, Example 7::3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US9598421, Example 7::US10669279, Example 7	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 2.35							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863065	378169173							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578934	Cn1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)c(F)c2)cn1	InChI=1S/C17H12ClFN6O/c1-24-9-11(8-21-24)22-17(26)15-16(10-4-5-12(18)13(19)7-10)25-14(23-15)3-2-6-20-25/h2-9H,1H3,(H,22,26)	LSCITVBMOOTYOS-UHFFFAOYSA-N	285534	US10077269, Example 7::3-(4-Chloro-3-fluorophenyl)-N-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide (7)::US9598421, Example 7::US10669279, Example 7	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 34.5							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285534	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285534&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863065	378169173							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578935	CN(C)c1ccc(cc1)P(C(C)(C)C)(C(C)(C)C)[Pd](Cl)(Cl)P(c1ccc(cc1)N(C)C)(C(C)(C)C)C(C)(C)C	InChI=1S/2C16H28NP.2ClH.Pd/c2*1-15(2,3)18(16(4,5)6)14-11-9-13(10-12-14)17(7)8;;;/h2*9-12H,1-8H3;2*1H;	AWOFSUFKCXRJMV-UHFFFAOYSA-N	302439	US9598421, Example 8::Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 20.0							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302439	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302439&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			58567970	381751175							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578936	CN(C)c1ccc(cc1)P(C(C)(C)C)(C(C)(C)C)[Pd](Cl)(Cl)P(c1ccc(cc1)N(C)C)(C(C)(C)C)C(C)(C)C	InChI=1S/2C16H28NP.2ClH.Pd/c2*1-15(2,3)18(16(4,5)6)14-11-9-13(10-12-14)17(7)8;;;/h2*9-12H,1-8H3;2*1H;	AWOFSUFKCXRJMV-UHFFFAOYSA-N	302439	US9598421, Example 8::Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 41.3							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302439	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302439&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			58567970	381751175							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578937	CN(C)c1ccc(cc1)P(C(C)(C)C)(C(C)(C)C)[Pd](Cl)(Cl)P(c1ccc(cc1)N(C)C)(C(C)(C)C)C(C)(C)C	InChI=1S/2C16H28NP.2ClH.Pd/c2*1-15(2,3)18(16(4,5)6)14-11-9-13(10-12-14)17(7)8;;;/h2*9-12H,1-8H3;2*1H;	AWOFSUFKCXRJMV-UHFFFAOYSA-N	302439	US9598421, Example 8::Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 64.9							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302439	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302439&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			58567970	381751175							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578938	CN(C)c1ccc(cc1)P(C(C)(C)C)(C(C)(C)C)[Pd](Cl)(Cl)P(c1ccc(cc1)N(C)C)(C(C)(C)C)C(C)(C)C	InChI=1S/2C16H28NP.2ClH.Pd/c2*1-15(2,3)18(16(4,5)6)14-11-9-13(10-12-14)17(7)8;;;/h2*9-12H,1-8H3;2*1H;	AWOFSUFKCXRJMV-UHFFFAOYSA-N	302439	US9598421, Example 8::Azetidin-1-yl[3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone (8)	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 5440							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=302439	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=302439&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			58567970	381751175							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578939	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl |(8.76,-6.6,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,;4.3,-7.8,;2.81,-8.2,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,)|	InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24)	IJGCWHSMOTWWLO-UHFFFAOYSA-N	285536	US10077269, Example 9::3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US9598421, Example 9::US10669279, Example 9	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 3.83							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118863077	378169175							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578940	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl |(8.76,-6.6,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,;4.3,-7.8,;2.81,-8.2,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,)|	InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24)	IJGCWHSMOTWWLO-UHFFFAOYSA-N	285536	US10077269, Example 9::3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US9598421, Example 9::US10669279, Example 9	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 10.5							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118863077	378169175							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578941	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl |(8.76,-6.6,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,;4.3,-7.8,;2.81,-8.2,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,)|	InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24)	IJGCWHSMOTWWLO-UHFFFAOYSA-N	285536	US10077269, Example 9::3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US9598421, Example 9::US10669279, Example 9	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 40.9							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118863077	378169175							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578942	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1Cl |(8.76,-6.6,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,;4.3,-7.8,;2.81,-8.2,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,)|	InChI=1S/C16H11ClF2N4O/c17-10-7-11(18)9(6-12(10)19)15-14(16(24)21-8-3-4-8)22-13-2-1-5-20-23(13)15/h1-2,5-8H,3-4H2,(H,21,24)	IJGCWHSMOTWWLO-UHFFFAOYSA-N	285536	US10077269, Example 9::3-(4-Chloro-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide (9)::US9598421, Example 9::US10669279, Example 9	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 1490							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285536	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285536&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118863077	378169175							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578943	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	VPDYRGHPOFWFHI-UHFFFAOYSA-N	285537	US10077269, Example 10::3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 10::US10669279, Example 10	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 1.51							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875363	378169176							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578944	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	VPDYRGHPOFWFHI-UHFFFAOYSA-N	285537	US10077269, Example 10::3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 10::US10669279, Example 10	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 3.80							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875363	378169176							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578945	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	VPDYRGHPOFWFHI-UHFFFAOYSA-N	285537	US10077269, Example 10::3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 10::US10669279, Example 10	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 6.84							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875363	378169176							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578946	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	VPDYRGHPOFWFHI-UHFFFAOYSA-N	285537	US10077269, Example 10::3-(4-chloro-3-fluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 10::US10669279, Example 10	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 590							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285537	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285537&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875363	378169176							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578947	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12Cl2N4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	HJVCDCPLKNQXFO-UHFFFAOYSA-N	285538	US10077269, Example 11::N-cyclopropyl-3-(3,4-di-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 11::US10669279, Example 11	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 1.60							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285538	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285538&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700151	378169177							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578948	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12Cl2N4O/c17-11-6-3-9(8-12(11)18)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	HJVCDCPLKNQXFO-UHFFFAOYSA-N	285538	US10077269, Example 11::N-cyclopropyl-3-(3,4-di-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 11::US10669279, Example 11	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 334							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285538	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285538&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700151	378169177							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578949	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,)|	InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23)	SRRULVNTICTTGE-UHFFFAOYSA-N	285539	US10077269, Example 12::3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 12::US10669279, Example 12	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 14.4							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875408	378169178							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578950	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,)|	InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23)	SRRULVNTICTTGE-UHFFFAOYSA-N	285539	US10077269, Example 12::3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 12::US10669279, Example 12	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 35.8							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875408	378169178							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578951	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,)|	InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23)	SRRULVNTICTTGE-UHFFFAOYSA-N	285539	US10077269, Example 12::3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 12::US10669279, Example 12	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 89.6							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875408	378169178							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578952	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.19,-5.91,;6.58,-4.43,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.38,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.44,-11.62,;8.21,-10.29,;8.21,-12.96,;9.75,-12.96,;11.08,-13.73,;11.08,-12.19,)|	InChI=1S/C17H15ClN4O/c1-10-9-11(18)4-7-13(10)16-15(17(23)20-12-5-6-12)21-14-3-2-8-19-22(14)16/h2-4,7-9,12H,5-6H2,1H3,(H,20,23)	SRRULVNTICTTGE-UHFFFAOYSA-N	285539	US10077269, Example 12::3-(4-chloro-2-methyl-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 12::US10669279, Example 12	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 5220							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285539	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285539&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875408	378169178							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578953	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	IVSBLXFZMFGIAK-UHFFFAOYSA-N	285540	US10077269, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 13::US10669279, Example 13	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 5.13							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700157	378169179							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578954	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	IVSBLXFZMFGIAK-UHFFFAOYSA-N	285540	US10077269, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 13::US10669279, Example 13	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 4.63							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700157	378169179							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578955	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	IVSBLXFZMFGIAK-UHFFFAOYSA-N	285540	US10077269, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 13::US10669279, Example 13	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 17.3							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700157	378169179							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578956	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12ClFN4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	IVSBLXFZMFGIAK-UHFFFAOYSA-N	285540	US10077269, Example 13::azetidin-1-yl[3-(4-chloro-3-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 13::US10669279, Example 13	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 669							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285540	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285540&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700157	378169179							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578957	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22)	BAWGMUZVOXOKPF-UHFFFAOYSA-N	285541	US10077269, Example 14::3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 14::US10669279, Example 14	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 73.7							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700152	378169180							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578958	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22)	BAWGMUZVOXOKPF-UHFFFAOYSA-N	285541	US10077269, Example 14::3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 14::US10669279, Example 14	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 79.1							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700152	378169180							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578959	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22)	BAWGMUZVOXOKPF-UHFFFAOYSA-N	285541	US10077269, Example 14::3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 14::US10669279, Example 14	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 108							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700152	378169180							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578960	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C15H12ClN5O/c16-10-6-9(7-17-8-10)14-13(15(22)19-11-3-4-11)20-12-2-1-5-18-21(12)14/h1-2,5-8,11H,3-4H2,(H,19,22)	BAWGMUZVOXOKPF-UHFFFAOYSA-N	285541	US10077269, Example 14::3-(5-chloropyridin-3-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 14::US10669279, Example 14	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>8010							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285541	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285541&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700152	378169180							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578961	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2	QELHEVBSVCAUHV-UHFFFAOYSA-N	285542	US10077269, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 15::US10669279, Example 15	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 264							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			125474237	378169181							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578962	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2	QELHEVBSVCAUHV-UHFFFAOYSA-N	285542	US10077269, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 15::US10669279, Example 15	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 252							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			125474237	378169181							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578963	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2	QELHEVBSVCAUHV-UHFFFAOYSA-N	285542	US10077269, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 15::US10669279, Example 15	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 421							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			125474237	378169181							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578964	Clc1cncc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C15H12ClN5O/c16-11-7-10(8-17-9-11)14-13(15(22)20-5-2-6-20)19-12-3-1-4-18-21(12)14/h1,3-4,7-9H,2,5-6H2	QELHEVBSVCAUHV-UHFFFAOYSA-N	285542	US10077269, Example 15::azetidin-1-yl[3-(5-chloro-pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 15::US10669279, Example 15	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>23700							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285542	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285542&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			125474237	378169181							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578965	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-6-18-23)11-4-5-12-17-10-19-22(12)9-11/h1,3-6,9-10H,2,7-8H2	WFFUVTXNYNORQT-UHFFFAOYSA-N	285543	US10077269, Example 16::azetidin-1-yl[3-([1,2,4]tri-azolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 16::US10669279, Example 16	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 552							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285543	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285543&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875381	378169182							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578966	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncnn2c1	InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-6-18-23)11-4-5-12-17-10-19-22(12)9-11/h1,3-6,9-10H,2,7-8H2	WFFUVTXNYNORQT-UHFFFAOYSA-N	285543	US10077269, Example 16::azetidin-1-yl[3-([1,2,4]tri-azolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 16::US10669279, Example 16	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>27500							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285543	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285543&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875381	378169182							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578967	Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N |(8.76,-6.6,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,;4.3,-7.8,;2.81,-8.2,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,)|	InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	SAWDLJNAAJBRMX-UHFFFAOYSA-N	285544	US10077269, Example 17::3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 17::US10669279, Example 17	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 89.9							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875411	378169183							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578968	Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N |(8.76,-6.6,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,;4.3,-7.8,;2.81,-8.2,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,)|	InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	SAWDLJNAAJBRMX-UHFFFAOYSA-N	285544	US10077269, Example 17::3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 17::US10669279, Example 17	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 175							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875411	378169183							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578969	Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N |(8.76,-6.6,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,;4.3,-7.8,;2.81,-8.2,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,)|	InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	SAWDLJNAAJBRMX-UHFFFAOYSA-N	285544	US10077269, Example 17::3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 17::US10669279, Example 17	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 216							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875411	378169183							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578970	Cc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N |(8.76,-6.6,;7.27,-7,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,;4.3,-7.8,;2.81,-8.2,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,)|	InChI=1S/C18H14FN5O/c1-10-7-13(14(19)8-11(10)9-20)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	SAWDLJNAAJBRMX-UHFFFAOYSA-N	285544	US10077269, Example 17::3-(4-cyano-2-fluoro-5-methylphenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 17::US10669279, Example 17	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>18200							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285544	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285544&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875411	378169183							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578971	Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N |(-2.3,-23.34,;-3.79,-23.74,;-4.19,-25.23,;-5.68,-25.62,;-6.08,-27.11,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-3.63,-28.36,;-2.86,-27.02,;-2.86,-29.69,;-3.26,-31.18,;-1.77,-31.58,;-1.37,-30.09,;-6.77,-24.54,;-8.25,-24.93,;-6.37,-23.05,;-4.88,-22.65,;-4.48,-21.16,;-4.16,-19.66,)|	InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	GGBPMJVCUHMAJB-UHFFFAOYSA-N	285545	US10077269, Example 18::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US9598421, Example 18::US10669279, Example 18	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 55.0							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700154	378169184							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578972	Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N |(-2.3,-23.34,;-3.79,-23.74,;-4.19,-25.23,;-5.68,-25.62,;-6.08,-27.11,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-3.63,-28.36,;-2.86,-27.02,;-2.86,-29.69,;-3.26,-31.18,;-1.77,-31.58,;-1.37,-30.09,;-6.77,-24.54,;-8.25,-24.93,;-6.37,-23.05,;-4.88,-22.65,;-4.48,-21.16,;-4.16,-19.66,)|	InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	GGBPMJVCUHMAJB-UHFFFAOYSA-N	285545	US10077269, Example 18::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US9598421, Example 18::US10669279, Example 18	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 150							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700154	378169184							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578973	Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N |(-2.3,-23.34,;-3.79,-23.74,;-4.19,-25.23,;-5.68,-25.62,;-6.08,-27.11,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-3.63,-28.36,;-2.86,-27.02,;-2.86,-29.69,;-3.26,-31.18,;-1.77,-31.58,;-1.37,-30.09,;-6.77,-24.54,;-8.25,-24.93,;-6.37,-23.05,;-4.88,-22.65,;-4.48,-21.16,;-4.16,-19.66,)|	InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	GGBPMJVCUHMAJB-UHFFFAOYSA-N	285545	US10077269, Example 18::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US9598421, Example 18::US10669279, Example 18	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 147							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700154	378169184							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578974	Cc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N |(-2.3,-23.34,;-3.79,-23.74,;-4.19,-25.23,;-5.68,-25.62,;-6.08,-27.11,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-3.63,-28.36,;-2.86,-27.02,;-2.86,-29.69,;-3.26,-31.18,;-1.77,-31.58,;-1.37,-30.09,;-6.77,-24.54,;-8.25,-24.93,;-6.37,-23.05,;-4.88,-22.65,;-4.48,-21.16,;-4.16,-19.66,)|	InChI=1S/C18H14FN5O/c1-11-8-13(14(19)9-12(11)10-20)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	GGBPMJVCUHMAJB-UHFFFAOYSA-N	285545	US10077269, Example 18::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-5-fluoro-2-methylbenzonitrile::US9598421, Example 18::US10669279, Example 18	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 8200							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285545	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285545&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700154	378169184							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578975	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,;7.27,-7,;8.76,-6.6,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,)|	InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	PMXQBXHVHKGVCD-UHFFFAOYSA-N	285546	US10077269, Example 19::3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 19::US10669279, Example 19	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 16.9							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875364	378169185							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578976	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,;7.27,-7,;8.76,-6.6,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,)|	InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	PMXQBXHVHKGVCD-UHFFFAOYSA-N	285546	US10077269, Example 19::3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 19::US10669279, Example 19	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 13.6							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875364	378169185							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578977	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,;7.27,-7,;8.76,-6.6,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,)|	InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	PMXQBXHVHKGVCD-UHFFFAOYSA-N	285546	US10077269, Example 19::3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 19::US10669279, Example 19	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 98.4							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875364	378169185							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578978	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(2.81,-8.2,;4.3,-7.8,;4.7,-6.31,;6.18,-5.91,;6.58,-4.42,;6.9,-2.92,;7.27,-7,;8.76,-6.6,;6.88,-8.49,;5.39,-8.89,;4.99,-10.37,;5.89,-11.62,;4.99,-12.87,;3.52,-12.39,;2.19,-13.16,;.86,-12.39,;.86,-10.85,;2.19,-10.08,;3.52,-10.85,;7.43,-11.62,;8.2,-10.29,;8.2,-12.95,;9.74,-12.95,;11.08,-13.72,;11.08,-12.18,)|	InChI=1S/C18H14FN5O/c1-10-7-11(9-20)14(19)8-13(10)17-16(18(25)22-12-4-5-12)23-15-3-2-6-21-24(15)17/h2-3,6-8,12H,4-5H2,1H3,(H,22,25)	PMXQBXHVHKGVCD-UHFFFAOYSA-N	285546	US10077269, Example 19::3-(4-cyano-5-fluoro-2-methylphenyl)-N-cyclo-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 19::US10669279, Example 19	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 645							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285546	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285546&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875364	378169185							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578979	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1 |(-8.25,-24.93,;-6.77,-24.54,;-6.37,-23.05,;-4.88,-22.65,;-4.48,-21.16,;-4.16,-19.66,;-3.79,-23.74,;-2.3,-23.34,;-4.19,-25.23,;-5.68,-25.62,;-6.08,-27.11,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-3.63,-28.36,;-2.86,-27.02,;-2.86,-29.69,;-3.26,-31.18,;-1.77,-31.58,;-1.37,-30.09,)|	InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	NJCCFDZQRIVPQK-UHFFFAOYSA-N	285547	US10077269, Example 20::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US9598421, Example 20::US10669279, Example 20	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 6.70							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126683777	378169186							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578980	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1 |(-8.25,-24.93,;-6.77,-24.54,;-6.37,-23.05,;-4.88,-22.65,;-4.48,-21.16,;-4.16,-19.66,;-3.79,-23.74,;-2.3,-23.34,;-4.19,-25.23,;-5.68,-25.62,;-6.08,-27.11,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-3.63,-28.36,;-2.86,-27.02,;-2.86,-29.69,;-3.26,-31.18,;-1.77,-31.58,;-1.37,-30.09,)|	InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	NJCCFDZQRIVPQK-UHFFFAOYSA-N	285547	US10077269, Example 20::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US9598421, Example 20::US10669279, Example 20	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 5.74							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126683777	378169186							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578981	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1 |(-8.25,-24.93,;-6.77,-24.54,;-6.37,-23.05,;-4.88,-22.65,;-4.48,-21.16,;-4.16,-19.66,;-3.79,-23.74,;-2.3,-23.34,;-4.19,-25.23,;-5.68,-25.62,;-6.08,-27.11,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-3.63,-28.36,;-2.86,-27.02,;-2.86,-29.69,;-3.26,-31.18,;-1.77,-31.58,;-1.37,-30.09,)|	InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	NJCCFDZQRIVPQK-UHFFFAOYSA-N	285547	US10077269, Example 20::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US9598421, Example 20::US10669279, Example 20	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 74.8							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126683777	378169186							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578982	Cc1cc(C#N)c(F)cc1-c1c(nc2cccnn12)C(=O)N1CCC1 |(-8.25,-24.93,;-6.77,-24.54,;-6.37,-23.05,;-4.88,-22.65,;-4.48,-21.16,;-4.16,-19.66,;-3.79,-23.74,;-2.3,-23.34,;-4.19,-25.23,;-5.68,-25.62,;-6.08,-27.11,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-3.63,-28.36,;-2.86,-27.02,;-2.86,-29.69,;-3.26,-31.18,;-1.77,-31.58,;-1.37,-30.09,)|	InChI=1S/C18H14FN5O/c1-11-8-12(10-20)14(19)9-13(11)17-16(18(25)23-6-3-7-23)22-15-4-2-5-21-24(15)17/h2,4-5,8-9H,3,6-7H2,1H3	NJCCFDZQRIVPQK-UHFFFAOYSA-N	285547	US10077269, Example 20::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluoro-5-methylbenzonitrile::US9598421, Example 20::US10669279, Example 20	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 490							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285547	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285547&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126683777	378169186							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578983	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3	VTRNMYGATDHWOK-UHFFFAOYSA-N	285548	US10077269, Example 21::3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 21::US10669279, Example 21	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 53.7							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700156	378169187							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578984	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3	VTRNMYGATDHWOK-UHFFFAOYSA-N	285548	US10077269, Example 21::3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 21::US10669279, Example 21	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 91.3							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700156	378169187							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578985	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3	VTRNMYGATDHWOK-UHFFFAOYSA-N	285548	US10077269, Example 21::3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 21::US10669279, Example 21	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 170							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700156	378169187							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578986	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C17H14ClFN4O/c1-22(11-5-6-11)17(24)15-16(10-4-7-12(18)13(19)9-10)23-14(21-15)3-2-8-20-23/h2-4,7-9,11H,5-6H2,1H3	VTRNMYGATDHWOK-UHFFFAOYSA-N	285548	US10077269, Example 21::3-(4-chloro-3-fluorophenyl)-N-cyclopropyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 21::US10669279, Example 21	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>12300							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285548	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285548&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700156	378169187							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578987	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24)	XWBNVRGWNULCLK-UHFFFAOYSA-N	285549	US10077269, Example 22::N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 22::US10669279, Example 22	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 27.6							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875403	378169188							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578988	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24)	XWBNVRGWNULCLK-UHFFFAOYSA-N	285549	US10077269, Example 22::N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 22::US10669279, Example 22	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 58.9							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875403	378169188							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578989	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24)	XWBNVRGWNULCLK-UHFFFAOYSA-N	285549	US10077269, Example 22::N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 22::US10669279, Example 22	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 71.2							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875403	378169188							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578990	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ccnn2c1	InChI=1S/C17H14N6O/c24-17(20-12-4-5-12)15-16(23-14(21-15)2-1-8-19-23)11-3-6-13-7-9-18-22(13)10-11/h1-3,6-10,12H,4-5H2,(H,20,24)	XWBNVRGWNULCLK-UHFFFAOYSA-N	285549	US10077269, Example 22::N-cyclopropyl-3-(pyrazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 22::US10669279, Example 22	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 1890							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285549	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285549&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875403	378169188							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578991	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2	COQGBMKNVJUVAB-UHFFFAOYSA-N	285550	US10077269, Example 23::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US9598421, Example 23::US10669279, Example 23	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 15.1							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700158	378169189							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578992	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2	COQGBMKNVJUVAB-UHFFFAOYSA-N	285550	US10077269, Example 23::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US9598421, Example 23::US10669279, Example 23	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 30.5							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700158	378169189							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578993	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2	COQGBMKNVJUVAB-UHFFFAOYSA-N	285550	US10077269, Example 23::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US9598421, Example 23::US10669279, Example 23	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 45.8							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700158	378169189							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578994	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12FN5O/c18-13-9-11(4-5-12(13)10-19)16-15(17(24)22-7-2-8-22)21-14-3-1-6-20-23(14)16/h1,3-6,9H,2,7-8H2	COQGBMKNVJUVAB-UHFFFAOYSA-N	285550	US10077269, Example 23::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-fluorobenzonitrile::US9598421, Example 23::US10669279, Example 23	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 4130							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285550	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285550&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700158	378169189							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578995	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N |(-2.3,-23.34,;-3.79,-23.74,;-4.19,-25.23,;-5.68,-25.62,;-6.08,-27.11,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-3.63,-28.36,;-2.86,-27.02,;-2.86,-29.69,;-3.26,-31.18,;-1.77,-31.58,;-1.37,-30.09,;-6.77,-24.54,;-8.25,-24.93,;-6.37,-23.05,;-4.88,-22.65,;-4.48,-21.16,;-4.16,-19.66,)|	InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2	GLYPDLWNQYDRTQ-UHFFFAOYSA-N	285551	US10077269, Example 24::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US9598421, Example 24::US10669279, Example 24	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 5.04							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700159	378169190							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578996	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N |(-2.3,-23.34,;-3.79,-23.74,;-4.19,-25.23,;-5.68,-25.62,;-6.08,-27.11,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-3.63,-28.36,;-2.86,-27.02,;-2.86,-29.69,;-3.26,-31.18,;-1.77,-31.58,;-1.37,-30.09,;-6.77,-24.54,;-8.25,-24.93,;-6.37,-23.05,;-4.88,-22.65,;-4.48,-21.16,;-4.16,-19.66,)|	InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2	GLYPDLWNQYDRTQ-UHFFFAOYSA-N	285551	US10077269, Example 24::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US9598421, Example 24::US10669279, Example 24	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 19.1							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700159	378169190							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578997	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N |(-2.3,-23.34,;-3.79,-23.74,;-4.19,-25.23,;-5.68,-25.62,;-6.08,-27.11,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-3.63,-28.36,;-2.86,-27.02,;-2.86,-29.69,;-3.26,-31.18,;-1.77,-31.58,;-1.37,-30.09,;-6.77,-24.54,;-8.25,-24.93,;-6.37,-23.05,;-4.88,-22.65,;-4.48,-21.16,;-4.16,-19.66,)|	InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2	GLYPDLWNQYDRTQ-UHFFFAOYSA-N	285551	US10077269, Example 24::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US9598421, Example 24::US10669279, Example 24	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 59.7							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700159	378169190							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578998	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1C#N |(-2.3,-23.34,;-3.79,-23.74,;-4.19,-25.23,;-5.68,-25.62,;-6.08,-27.11,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-3.63,-28.36,;-2.86,-27.02,;-2.86,-29.69,;-3.26,-31.18,;-1.77,-31.58,;-1.37,-30.09,;-6.77,-24.54,;-8.25,-24.93,;-6.37,-23.05,;-4.88,-22.65,;-4.48,-21.16,;-4.16,-19.66,)|	InChI=1S/C17H11F2N5O/c18-12-8-11(13(19)7-10(12)9-20)16-15(17(25)23-5-2-6-23)22-14-3-1-4-21-24(14)16/h1,3-4,7-8H,2,5-6H2	GLYPDLWNQYDRTQ-UHFFFAOYSA-N	285551	US10077269, Example 24::4-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-2,5-difluorobenzonitrile::US9598421, Example 24::US10669279, Example 24	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>2150							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285551	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285551&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700159	378169190							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
578999	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C |(-3.63,-31.03,;-2.86,-29.69,;-3.63,-28.36,;-2.86,-27.02,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-6.08,-27.11,;-5.68,-25.62,;-4.19,-25.23,;-3.79,-23.74,;-2.3,-23.34,;-4.88,-22.65,;-4.48,-21.16,;-6.37,-23.05,;-6.77,-24.54,;-8.25,-24.93,)|	InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22)	APQCTKWSIMEXKR-UHFFFAOYSA-N	285552	US10077269, Example 25::3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 25::US10669279, Example 25	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 38.6							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875410	378169191							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579000	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C |(-3.63,-31.03,;-2.86,-29.69,;-3.63,-28.36,;-2.86,-27.02,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-6.08,-27.11,;-5.68,-25.62,;-4.19,-25.23,;-3.79,-23.74,;-2.3,-23.34,;-4.88,-22.65,;-4.48,-21.16,;-6.37,-23.05,;-6.77,-24.54,;-8.25,-24.93,)|	InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22)	APQCTKWSIMEXKR-UHFFFAOYSA-N	285552	US10077269, Example 25::3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 25::US10669279, Example 25	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 140							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875410	378169191							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579001	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C |(-3.63,-31.03,;-2.86,-29.69,;-3.63,-28.36,;-2.86,-27.02,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-6.08,-27.11,;-5.68,-25.62,;-4.19,-25.23,;-3.79,-23.74,;-2.3,-23.34,;-4.88,-22.65,;-4.48,-21.16,;-6.37,-23.05,;-6.77,-24.54,;-8.25,-24.93,)|	InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22)	APQCTKWSIMEXKR-UHFFFAOYSA-N	285552	US10077269, Example 25::3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 25::US10669279, Example 25	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 150							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875410	378169191							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579002	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C |(-3.63,-31.03,;-2.86,-29.69,;-3.63,-28.36,;-2.86,-27.02,;-5.17,-28.36,;-6.08,-29.6,;-7.54,-29.13,;-8.87,-29.9,;-10.21,-29.13,;-10.21,-27.59,;-8.87,-26.82,;-7.54,-27.59,;-6.08,-27.11,;-5.68,-25.62,;-4.19,-25.23,;-3.79,-23.74,;-2.3,-23.34,;-4.88,-22.65,;-4.48,-21.16,;-6.37,-23.05,;-6.77,-24.54,;-8.25,-24.93,)|	InChI=1S/C15H12ClFN4O/c1-8-6-10(16)11(17)7-9(8)14-13(15(22)18-2)20-12-4-3-5-19-21(12)14/h3-7H,1-2H3,(H,18,22)	APQCTKWSIMEXKR-UHFFFAOYSA-N	285552	US10077269, Example 25::3-(4-chloro-5-fluoro-2-methylphenyl)-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 25::US10669279, Example 25	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 4970							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285552	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285552&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875410	378169191							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579003	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22)	VDPHNQHKTFMQPH-UHFFFAOYSA-N	285553	US10077269, Example 26::3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 26::US10669279, Example 26	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 85.5							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875372	378169192							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579004	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22)	VDPHNQHKTFMQPH-UHFFFAOYSA-N	285553	US10077269, Example 26::3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 26::US10669279, Example 26	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 114							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875372	378169192							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579005	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22)	VDPHNQHKTFMQPH-UHFFFAOYSA-N	285553	US10077269, Example 26::3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 26::US10669279, Example 26	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 111							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875372	378169192							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579006	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H15ClN4O/c1-2-9-18-16(22)14-15(11-5-7-12(17)8-6-11)21-13(20-14)4-3-10-19-21/h3-8,10H,2,9H2,1H3,(H,18,22)	VDPHNQHKTFMQPH-UHFFFAOYSA-N	285553	US10077269, Example 26::3-(4-chlorophenyl)-N-propyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 26::US10669279, Example 26	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3800							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285553	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285553&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875372	378169192							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579007	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2	VGOMARAKBZMHJT-UHFFFAOYSA-N	285554	US10077269, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone::US9598421, Example 27::US10669279, Example 27	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 742							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875398	378169193							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579008	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2	VGOMARAKBZMHJT-UHFFFAOYSA-N	285554	US10077269, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone::US9598421, Example 27::US10669279, Example 27	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 609							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875398	378169193							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579009	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2	VGOMARAKBZMHJT-UHFFFAOYSA-N	285554	US10077269, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone::US9598421, Example 27::US10669279, Example 27	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 768							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875398	378169193							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579010	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)N1CCCC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)21-10-1-2-11-21)20-14-4-3-9-19-22(14)16/h3-9H,1-2,10-11H2	VGOMARAKBZMHJT-UHFFFAOYSA-N	285554	US10077269, Example 27::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](pyrrolidin-1-yl)methanone::US9598421, Example 27::US10669279, Example 27	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 5620							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285554	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285554&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875398	378169193							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579011	CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1	InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	GXYHCJBIWBLNEK-UHFFFAOYSA-N	285555	US10077269, Example 28::3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 28::US10669279, Example 28	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 15.6							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875386	378169194							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579012	CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1	InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	GXYHCJBIWBLNEK-UHFFFAOYSA-N	285555	US10077269, Example 28::3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 28::US10669279, Example 28	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 31.7							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875386	378169194							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579013	CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1	InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	GXYHCJBIWBLNEK-UHFFFAOYSA-N	285555	US10077269, Example 28::3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 28::US10669279, Example 28	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 49.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875386	378169194							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579014	CCCNC(=O)c1nc2cccnn2c1-c1cc(Cl)cc(Cl)c1	InChI=1S/C16H14Cl2N4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	GXYHCJBIWBLNEK-UHFFFAOYSA-N	285555	US10077269, Example 28::3-(3,5-dichlorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 28::US10669279, Example 28	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 393							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285555	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285555&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875386	378169194							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579015	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23)	ZOPYTZDTLDQKKZ-UHFFFAOYSA-N	285556	US10077269, Example 29::3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 29::US10669279, Example 29	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 3.48							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875384	378169195							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579016	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23)	ZOPYTZDTLDQKKZ-UHFFFAOYSA-N	285556	US10077269, Example 29::3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 29::US10669279, Example 29	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 5.05							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875384	378169195							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579017	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23)	ZOPYTZDTLDQKKZ-UHFFFAOYSA-N	285556	US10077269, Example 29::3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 29::US10669279, Example 29	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 13.8							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875384	378169195							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579018	CCCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C16H14ClFN4O/c1-2-7-19-16(23)14-15(10-5-6-11(17)12(18)9-10)22-13(21-14)4-3-8-20-22/h3-6,8-9H,2,7H2,1H3,(H,19,23)	ZOPYTZDTLDQKKZ-UHFFFAOYSA-N	285556	US10077269, Example 29::3-(4-chloro-3-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 29::US10669279, Example 29	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 409							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285556	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285556&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875384	378169195							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579019	CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23)	VSOPHYORBVNBMU-UHFFFAOYSA-N	285557	US10077269, Example 30::3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 30::US10669279, Example 30	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 11.6							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700166	378169196							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579020	CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23)	VSOPHYORBVNBMU-UHFFFAOYSA-N	285557	US10077269, Example 30::3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 30::US10669279, Example 30	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 55.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700166	378169196							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579021	CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23)	VSOPHYORBVNBMU-UHFFFAOYSA-N	285557	US10077269, Example 30::3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 30::US10669279, Example 30	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 24.5							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700166	378169196							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579022	CC1CC1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-10-9-13(10)20-17(23)15-16(11-4-6-12(18)7-5-11)22-14(21-15)3-2-8-19-22/h2-8,10,13H,9H2,1H3,(H,20,23)	VSOPHYORBVNBMU-UHFFFAOYSA-N	285557	US10077269, Example 30::3-(4-chlorophenyl)-N-(2-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 30::US10669279, Example 30	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 4000							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285557	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285557&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700166	378169196							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579023	COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3	WJDDXTCEGQNYBD-UHFFFAOYSA-N	285558	US10077269, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone::US9598421, Example 31::US10669279, Example 31	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 2820							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700165	378169197							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579024	COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3	WJDDXTCEGQNYBD-UHFFFAOYSA-N	285558	US10077269, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone::US9598421, Example 31::US10669279, Example 31	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 2670							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700165	378169197							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579025	COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3	WJDDXTCEGQNYBD-UHFFFAOYSA-N	285558	US10077269, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone::US9598421, Example 31::US10669279, Example 31	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 5810							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700165	378169197							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579026	COC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O2/c1-24-13-9-21(10-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-8-19-22/h2-8,13H,9-10H2,1H3	WJDDXTCEGQNYBD-UHFFFAOYSA-N	285558	US10077269, Example 31::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-methoxy-azetidin-1-yl)methanone::US9598421, Example 31::US10669279, Example 31	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		<26200							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285558	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285558&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700165	378169197							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579027	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3	YRYSHRMLXGRWSA-UHFFFAOYSA-N	285559	US10077269, Example 32::3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 32::US10669279, Example 32	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 1030							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875382	378169198							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579028	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3	YRYSHRMLXGRWSA-UHFFFAOYSA-N	285559	US10077269, Example 32::3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 32::US10669279, Example 32	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 419							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875382	378169198							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579029	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3	YRYSHRMLXGRWSA-UHFFFAOYSA-N	285559	US10077269, Example 32::3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 32::US10669279, Example 32	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 469							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875382	378169198							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579030	CN(C1CC1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-21(13-8-9-13)17(23)15-16(11-4-6-12(18)7-5-11)22-14(20-15)3-2-10-19-22/h2-7,10,13H,8-9H2,1H3	YRYSHRMLXGRWSA-UHFFFAOYSA-N	285559	US10077269, Example 32::3-(4-chlorophenyl)-N-cyclo-propyl-N-methyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 32::US10669279, Example 32	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>30000							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285559	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285559&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875382	378169198							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579031	CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23)	DJBROLKNQFDUKD-UHFFFAOYSA-N	285560	US10077269, Example 33::3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 33::US10669279, Example 33	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 58.6							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700164	378169199							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579032	CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23)	DJBROLKNQFDUKD-UHFFFAOYSA-N	285560	US10077269, Example 33::3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 33::US10669279, Example 33	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 53.6							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700164	378169199							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579033	CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23)	DJBROLKNQFDUKD-UHFFFAOYSA-N	285560	US10077269, Example 33::3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 33::US10669279, Example 33	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 127							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700164	378169199							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579034	CC1(CC1)NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C17H15ClN4O/c1-17(8-9-17)21-16(23)14-15(11-4-6-12(18)7-5-11)22-13(20-14)3-2-10-19-22/h2-7,10H,8-9H2,1H3,(H,21,23)	DJBROLKNQFDUKD-UHFFFAOYSA-N	285560	US10077269, Example 33::3-(4-chlorophenyl)-N-(1-methylcyclopropyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 33::US10669279, Example 33	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2330							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285560	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285560&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700164	378169199							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579035	CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1	InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	SRLHMGKYTUHFKW-UHFFFAOYSA-N	285561	US10077269, Example 34::3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 34::US10669279, Example 34	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 29.5							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875377	378169200							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579036	CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1	InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	SRLHMGKYTUHFKW-UHFFFAOYSA-N	285561	US10077269, Example 34::3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 34::US10669279, Example 34	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 83.2							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875377	378169200							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579037	CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1	InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	SRLHMGKYTUHFKW-UHFFFAOYSA-N	285561	US10077269, Example 34::3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 34::US10669279, Example 34	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 47.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875377	378169200							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579038	CCCNC(=O)c1nc2cccnn2c1-c1cc(F)cc(Cl)c1	InChI=1S/C16H14ClFN4O/c1-2-5-19-16(23)14-15(10-7-11(17)9-12(18)8-10)22-13(21-14)4-3-6-20-22/h3-4,6-9H,2,5H2,1H3,(H,19,23)	SRLHMGKYTUHFKW-UHFFFAOYSA-N	285561	US10077269, Example 34::3-(3-chloro-5-fluorophenyl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 34::US10669279, Example 34	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2110							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285561	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285561&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875377	378169200							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579039	Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23)	JXDYJNOWRSRYDW-UHFFFAOYSA-N	285562	US10077269, Example 35::3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 35::US10669279, Example 35	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 35.7							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875400	378169201							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579040	Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23)	JXDYJNOWRSRYDW-UHFFFAOYSA-N	285562	US10077269, Example 35::3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 35::US10669279, Example 35	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 48.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875400	378169201							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579041	Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23)	JXDYJNOWRSRYDW-UHFFFAOYSA-N	285562	US10077269, Example 35::3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 35::US10669279, Example 35	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 37.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875400	378169201							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579042	Fc1cc(Cl)cc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12ClFN4O/c17-10-6-9(7-11(18)8-10)15-14(16(23)20-12-3-4-12)21-13-2-1-5-19-22(13)15/h1-2,5-8,12H,3-4H2,(H,20,23)	JXDYJNOWRSRYDW-UHFFFAOYSA-N	285562	US10077269, Example 35::3-(3-chloro-5-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 35::US10669279, Example 35	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 1220							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285562	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285562&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875400	378169201							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579043	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22)	ZQTGMZNEQOGOQC-UHFFFAOYSA-N	285563	US10077269, Example 36::3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 36::US10669279, Example 36	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 23.7							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875416	378169202							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579044	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22)	ZQTGMZNEQOGOQC-UHFFFAOYSA-N	285563	US10077269, Example 36::3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 36::US10669279, Example 36	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 6.99							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875416	378169202							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579045	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22)	ZQTGMZNEQOGOQC-UHFFFAOYSA-N	285563	US10077269, Example 36::3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 36::US10669279, Example 36	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 21.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875416	378169202							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579046	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13ClN4O/c17-11-4-1-3-10(9-11)15-14(16(22)19-12-6-7-12)20-13-5-2-8-18-21(13)15/h1-5,8-9,12H,6-7H2,(H,19,22)	ZQTGMZNEQOGOQC-UHFFFAOYSA-N	285563	US10077269, Example 36::3-(3-chlorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 36::US10669279, Example 36	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 254							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285563	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285563&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875416	378169202							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579047	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2	InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24)	COONGBDOJFYLER-UHFFFAOYSA-N	285564	US10077269, Example 37::N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 37::US10669279, Example 37	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 127							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700169	378169203							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579048	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2	InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24)	COONGBDOJFYLER-UHFFFAOYSA-N	285564	US10077269, Example 37::N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 37::US10669279, Example 37	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 75.3							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700169	378169203							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579049	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2	InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24)	COONGBDOJFYLER-UHFFFAOYSA-N	285564	US10077269, Example 37::N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 37::US10669279, Example 37	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 161							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700169	378169203							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579050	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NC12CC(C1)C2	InChI=1S/C18H15ClN4O/c19-13-5-3-12(4-6-13)16-15(21-14-2-1-7-20-23(14)16)17(24)22-18-8-11(9-18)10-18/h1-7,11H,8-10H2,(H,22,24)	COONGBDOJFYLER-UHFFFAOYSA-N	285564	US10077269, Example 37::N-(bicyclo[1.1.1]pent-1-yl)-3-(4-chlorophenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 37::US10669279, Example 37	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2570							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285564	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285564&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700169	378169203							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579051	O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-3-4-11)15-16(22-14(21-15)2-1-6-19-22)10-8-13-12(18-9-10)5-7-24-13/h1-2,5-9,11H,3-4H2,(H,20,23)	XQQOHFBKZLHZIC-UHFFFAOYSA-N	285565	US10077269, Example 38::N-cyclopropyl-3-(furo[3,2-b]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 38::US10669279, Example 38	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 268							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285565	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285565&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700168	378169204							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579052	O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-3-4-11)15-16(22-14(21-15)2-1-6-19-22)10-8-13-12(18-9-10)5-7-24-13/h1-2,5-9,11H,3-4H2,(H,20,23)	XQQOHFBKZLHZIC-UHFFFAOYSA-N	285565	US10077269, Example 38::N-cyclopropyl-3-(furo[3,2-b]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 38::US10669279, Example 38	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 11200							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285565	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285565&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700168	378169204							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579053	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23)	WBVHJGBFCGWOMH-UHFFFAOYSA-N	285566	US10077269, Example 39::3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 39::US10669279, Example 39	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 14.8							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700170	378169205							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579054	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23)	WBVHJGBFCGWOMH-UHFFFAOYSA-N	285566	US10077269, Example 39::3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 39::US10669279, Example 39	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 26.5							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700170	378169205							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579055	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23)	WBVHJGBFCGWOMH-UHFFFAOYSA-N	285566	US10077269, Example 39::3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 39::US10669279, Example 39	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 67.8							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700170	378169205							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579056	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ocnc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-13-12(8-10)18-9-24-13/h1-3,6-9,11H,4-5H2,(H,20,23)	WBVHJGBFCGWOMH-UHFFFAOYSA-N	285566	US10077269, Example 39::3-(1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 39::US10669279, Example 39	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3820							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285566	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285566&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700170	378169205							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579057	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(-3.16,.88,;-1.67,1.28,;-1.27,2.76,;.22,3.16,;.62,4.65,;1.31,2.07,;.91,.59,;-.58,.19,;-.98,-1.3,;-.07,-2.55,;-.98,-3.79,;-2.44,-3.32,;-3.78,-4.09,;-5.11,-3.32,;-5.11,-1.78,;-3.78,-1.01,;-2.44,-1.78,;1.47,-2.55,;2.24,-1.21,;2.24,-3.88,;3.78,-3.88,;5.11,-4.65,;5.11,-3.11,)|	InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	WMBGBRRUSMUDQB-UHFFFAOYSA-N	285567	US10077269, Example 40::3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 40::US10669279, Example 40	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 19.6							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875401	378169206							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579058	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(-3.16,.88,;-1.67,1.28,;-1.27,2.76,;.22,3.16,;.62,4.65,;1.31,2.07,;.91,.59,;-.58,.19,;-.98,-1.3,;-.07,-2.55,;-.98,-3.79,;-2.44,-3.32,;-3.78,-4.09,;-5.11,-3.32,;-5.11,-1.78,;-3.78,-1.01,;-2.44,-1.78,;1.47,-2.55,;2.24,-1.21,;2.24,-3.88,;3.78,-3.88,;5.11,-4.65,;5.11,-3.11,)|	InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	WMBGBRRUSMUDQB-UHFFFAOYSA-N	285567	US10077269, Example 40::3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 40::US10669279, Example 40	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 65.3							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875401	378169206							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579059	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(-3.16,.88,;-1.67,1.28,;-1.27,2.76,;.22,3.16,;.62,4.65,;1.31,2.07,;.91,.59,;-.58,.19,;-.98,-1.3,;-.07,-2.55,;-.98,-3.79,;-2.44,-3.32,;-3.78,-4.09,;-5.11,-3.32,;-5.11,-1.78,;-3.78,-1.01,;-2.44,-1.78,;1.47,-2.55,;2.24,-1.21,;2.24,-3.88,;3.78,-3.88,;5.11,-4.65,;5.11,-3.11,)|	InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	WMBGBRRUSMUDQB-UHFFFAOYSA-N	285567	US10077269, Example 40::3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 40::US10669279, Example 40	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 58.1							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875401	378169206							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579060	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(-3.16,.88,;-1.67,1.28,;-1.27,2.76,;.22,3.16,;.62,4.65,;1.31,2.07,;.91,.59,;-.58,.19,;-.98,-1.3,;-.07,-2.55,;-.98,-3.79,;-2.44,-3.32,;-3.78,-4.09,;-5.11,-3.32,;-5.11,-1.78,;-3.78,-1.01,;-2.44,-1.78,;1.47,-2.55,;2.24,-1.21,;2.24,-3.88,;3.78,-3.88,;5.11,-4.65,;5.11,-3.11,)|	InChI=1S/C16H12ClFN4O/c17-9-3-6-11(12(18)8-9)15-14(16(23)20-10-4-5-10)21-13-2-1-7-19-22(13)15/h1-3,6-8,10H,4-5H2,(H,20,23)	WMBGBRRUSMUDQB-UHFFFAOYSA-N	285567	US10077269, Example 40::3-(4-chloro-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 40::US10669279, Example 40	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 9020							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285567	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285567&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875401	378169206							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579061	Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23)	XXAZCHDKOQBDMG-UHFFFAOYSA-N	285568	US10077269, Example 41::N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 41::US10669279, Example 41	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 3.13							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700171	378169207							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579062	Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23)	XXAZCHDKOQBDMG-UHFFFAOYSA-N	285568	US10077269, Example 41::N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 41::US10669279, Example 41	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 8.05							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700171	378169207							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579063	Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23)	XXAZCHDKOQBDMG-UHFFFAOYSA-N	285568	US10077269, Example 41::N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 41::US10669279, Example 41	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 16.8							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700171	378169207							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579064	Cc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H15FN4O/c1-10-4-5-11(9-13(10)18)16-15(17(23)20-12-6-7-12)21-14-3-2-8-19-22(14)16/h2-5,8-9,12H,6-7H2,1H3,(H,20,23)	XXAZCHDKOQBDMG-UHFFFAOYSA-N	285568	US10077269, Example 41::N-cyclopropyl-3-(3-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 41::US10669279, Example 41	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 467							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285568	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285568&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700171	378169207							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579065	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25)	QJYXPHGWTACNMO-UHFFFAOYSA-N	285569	US10077269, Example 42::N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 42::US10669279, Example 42	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 415							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875412	378169208							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579066	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25)	QJYXPHGWTACNMO-UHFFFAOYSA-N	285569	US10077269, Example 42::N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 42::US10669279, Example 42	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 393							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875412	378169208							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579067	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25)	QJYXPHGWTACNMO-UHFFFAOYSA-N	285569	US10077269, Example 42::N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 42::US10669279, Example 42	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 357							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875412	378169208							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579068	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-8-9(5-7-20-11)14-13(15(25)22-10-3-4-10)23-12-2-1-6-21-24(12)14/h1-2,5-8,10H,3-4H2,(H,22,25)	QJYXPHGWTACNMO-UHFFFAOYSA-N	285569	US10077269, Example 42::N-cyclopropyl-3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 42::US10669279, Example 42	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		<12200							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285569	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285569&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875412	378169208							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579069	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-9-10(4-6-20-11)14-13(15(25)23-7-2-8-23)22-12-3-1-5-21-24(12)14/h1,3-6,9H,2,7-8H2	GXXYJNKWPOFUGD-UHFFFAOYSA-N	285570	US10077269, Example 43::azetidin-1-yl{3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone::US9598421, Example 43::US10669279, Example 43	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 270							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285570	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285570&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875413	378169209							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579070	FC(F)(F)c1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12F3N5O/c17-16(18,19)11-9-10(4-6-20-11)14-13(15(25)23-7-2-8-23)22-12-3-1-5-21-24(12)14/h1,3-6,9H,2,7-8H2	GXXYJNKWPOFUGD-UHFFFAOYSA-N	285570	US10077269, Example 43::azetidin-1-yl{3-[2-(tri-fluoromethyl)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone::US9598421, Example 43::US10669279, Example 43	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>16900							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285570	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285570&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875413	378169209							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579071	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1(F)F	InChI=1S/C16H10ClF3N4O/c17-9-4-3-8(6-10(9)18)14-13(15(25)22-11-7-16(11,19)20)23-12-2-1-5-21-24(12)14/h1-6,11H,7H2,(H,22,25)	LLYJCFVFPOZAJN-UHFFFAOYSA-N	285571	US10077269, Example 44::3-(4-chloro-3-fluorophenyl)-N-(2,2-difluorocyclopro-pyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 44::US10669279, Example 44	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 3.92							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285571	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285571&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875387	378169210							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579072	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1(F)F	InChI=1S/C16H10ClF3N4O/c17-9-4-3-8(6-10(9)18)14-13(15(25)22-11-7-16(11,19)20)23-12-2-1-5-21-24(12)14/h1-6,11H,7H2,(H,22,25)	LLYJCFVFPOZAJN-UHFFFAOYSA-N	285571	US10077269, Example 44::3-(4-chloro-3-fluorophenyl)-N-(2,2-difluorocyclopro-pyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 44::US10669279, Example 44	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 320							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285571	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285571&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875387	378169210							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579073	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1 |r|	InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)	QSRJUMJDYNOQBS-UHFFFAOYSA-N	285572	US10077269, Example 45::3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 45::US10669279, Example 45	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 2.91							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700172	378169211							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579074	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1 |r|	InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)	QSRJUMJDYNOQBS-UHFFFAOYSA-N	285572	US10077269, Example 45::3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 45::US10669279, Example 45	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 1.97							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700172	378169211							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579075	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1 |r|	InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)	QSRJUMJDYNOQBS-UHFFFAOYSA-N	285572	US10077269, Example 45::3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 45::US10669279, Example 45	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 11.7							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700172	378169211							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579076	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1 |r|	InChI=1S/C16H11ClF2N4O/c17-9-4-3-8(6-10(9)18)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)	QSRJUMJDYNOQBS-UHFFFAOYSA-N	285572	US10077269, Example 45::3-(4-chloro-3-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 45::US10669279, Example 45	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 159							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285572	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285572&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700172	378169211							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579077	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 |r|	InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)	LROCAZWHWFXPFN-UHFFFAOYSA-N	285573	US10077269, Example 46::3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 46::US10669279, Example 46	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 15.2							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700173	378169212							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579078	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 |r|	InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)	LROCAZWHWFXPFN-UHFFFAOYSA-N	285573	US10077269, Example 46::3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 46::US10669279, Example 46	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 12.3							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700173	378169212							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579079	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 |r|	InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)	LROCAZWHWFXPFN-UHFFFAOYSA-N	285573	US10077269, Example 46::3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 46::US10669279, Example 46	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 39.3							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700173	378169212							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579080	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1 |r|	InChI=1S/C16H12ClFN4O/c17-10-5-3-9(4-6-10)15-14(16(23)20-12-8-11(12)18)21-13-2-1-7-19-22(13)15/h1-7,11-12H,8H2,(H,20,23)	LROCAZWHWFXPFN-UHFFFAOYSA-N	285573	US10077269, Example 46::3-(4-chlorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 46::US10669279, Example 46	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 971							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285573	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285573&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700173	378169212							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579081	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2	UGUNGNPFDJUJNI-UHFFFAOYSA-N	285574	US10077269, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 47::US10669279, Example 47	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 7.37							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700174	378169213							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579082	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2	UGUNGNPFDJUJNI-UHFFFAOYSA-N	285574	US10077269, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 47::US10669279, Example 47	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 3.90							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700174	378169213							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579083	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2	UGUNGNPFDJUJNI-UHFFFAOYSA-N	285574	US10077269, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 47::US10669279, Example 47	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 23.9							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700174	378169213							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579084	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)7-9(8-11(13)19)15-14(16(24)22-5-2-6-22)21-12-3-1-4-20-23(12)15/h1,3-4,7-8H,2,5-6H2	UGUNGNPFDJUJNI-UHFFFAOYSA-N	285574	US10077269, Example 47::azetidin-1-yl[3-(4-chloro-3,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 47::US10669279, Example 47	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 334							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285574	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285574&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700174	378169213							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579085	CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22)	XXRCLGJTXPMSDT-UHFFFAOYSA-N	285575	US10077269, Example 48::3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 48::US10669279, Example 48	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 768							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875389	378169214							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579086	CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22)	XXRCLGJTXPMSDT-UHFFFAOYSA-N	285575	US10077269, Example 48::3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 48::US10669279, Example 48	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 322							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875389	378169214							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579087	CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22)	XXRCLGJTXPMSDT-UHFFFAOYSA-N	285575	US10077269, Example 48::3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 48::US10669279, Example 48	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 212							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875389	378169214							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579088	CCCNC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1	InChI=1S/C15H14ClN5O/c1-2-5-18-15(22)13-14(10-7-11(16)9-17-8-10)21-12(20-13)4-3-6-19-21/h3-4,6-9H,2,5H2,1H3,(H,18,22)	XXRCLGJTXPMSDT-UHFFFAOYSA-N	285575	US10077269, Example 48::3-(5-chloropyridin-3-yl)-N-propylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 48::US10669279, Example 48	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>7670							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285575	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285575&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875389	378169214							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579089	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	MBBSPQBGJJWYLF-UHFFFAOYSA-N	285576	US10077269, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 49::US10669279, Example 49	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 4.16							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875405	378169215							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579090	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	MBBSPQBGJJWYLF-UHFFFAOYSA-N	285576	US10077269, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 49::US10669279, Example 49	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 13.3							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875405	378169215							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579091	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	MBBSPQBGJJWYLF-UHFFFAOYSA-N	285576	US10077269, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 49::US10669279, Example 49	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 19.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875405	378169215							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579092	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-5-6-12(10-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	MBBSPQBGJJWYLF-UHFFFAOYSA-N	285576	US10077269, Example 49::azetidin-1-yl[3-(3-chloro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 49::US10669279, Example 49	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 535							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285576	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285576&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875405	378169215							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579093	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1	InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2	HVVGNLROCIOALI-UHFFFAOYSA-N	285577	US10077269, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 50::US10669279, Example 50	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 28.1							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700175	378169216							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579094	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1	InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2	HVVGNLROCIOALI-UHFFFAOYSA-N	285577	US10077269, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 50::US10669279, Example 50	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 116							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700175	378169216							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579095	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1	InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2	HVVGNLROCIOALI-UHFFFAOYSA-N	285577	US10077269, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 50::US10669279, Example 50	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 235							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700175	378169216							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579096	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCc2c1	InChI=1S/C18H16N4O2/c23-18(21-8-2-9-21)16-17(22-15(20-16)3-1-7-19-22)13-4-5-14-12(11-13)6-10-24-14/h1,3-5,7,11H,2,6,8-10H2	HVVGNLROCIOALI-UHFFFAOYSA-N	285577	US10077269, Example 50::azetidin-1-yl[3-(2,3-dihydro-1-benzofuran-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 50::US10669279, Example 50	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3140							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285577	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285577&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700175	378169216							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579097	Cc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(5-6-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	TZEKFEDRWKCDSN-UHFFFAOYSA-N	285578	US10077269, Example 51::azetidin-1-yl[3-(4-chloro-3-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 51::US10669279, Example 51	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 42.9							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285578	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285578&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700177	378169217							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579098	Cc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15ClN4O/c1-11-10-12(5-6-13(11)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	TZEKFEDRWKCDSN-UHFFFAOYSA-N	285578	US10077269, Example 51::azetidin-1-yl[3-(4-chloro-3-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 51::US10669279, Example 51	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2810							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285578	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285578&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700177	378169217							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579099	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1 |(-2.46,1.44,;-.98,1.83,;-.58,3.32,;.91,3.72,;1.31,5.21,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,)|	InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	FRHMLRQQIOCJKU-UHFFFAOYSA-N	285579	US10077269, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 52::US10669279, Example 52	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 24.3							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700176	378169218							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579100	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1 |(-2.46,1.44,;-.98,1.83,;-.58,3.32,;.91,3.72,;1.31,5.21,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,)|	InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	FRHMLRQQIOCJKU-UHFFFAOYSA-N	285579	US10077269, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 52::US10669279, Example 52	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 37.3							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700176	378169218							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579101	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1 |(-2.46,1.44,;-.98,1.83,;-.58,3.32,;.91,3.72,;1.31,5.21,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,)|	InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	FRHMLRQQIOCJKU-UHFFFAOYSA-N	285579	US10077269, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 52::US10669279, Example 52	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 113							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700176	378169218							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579102	Fc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1 |(-2.46,1.44,;-.98,1.83,;-.58,3.32,;.91,3.72,;1.31,5.21,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,)|	InChI=1S/C16H12ClFN4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	FRHMLRQQIOCJKU-UHFFFAOYSA-N	285579	US10077269, Example 52::azetidin-1-yl[3-(4-chloro-2-fluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 52::US10669279, Example 52	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 5510							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285579	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285579&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700176	378169218							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579103	Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3	CTXZJNXACMKAGH-UHFFFAOYSA-N	285580	US10077269, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 53::US10669279, Example 53	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 17.8							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700178	378169219							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579104	Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3	CTXZJNXACMKAGH-UHFFFAOYSA-N	285580	US10077269, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 53::US10669279, Example 53	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 63.3							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700178	378169219							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579105	Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3	CTXZJNXACMKAGH-UHFFFAOYSA-N	285580	US10077269, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 53::US10669279, Example 53	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 153							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700178	378169219							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579106	Cc1cc(cc(C)c1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C18H17FN4O/c1-11-9-13(10-12(2)15(11)19)17-16(18(24)22-7-4-8-22)21-14-5-3-6-20-23(14)17/h3,5-6,9-10H,4,7-8H2,1-2H3	CTXZJNXACMKAGH-UHFFFAOYSA-N	285580	US10077269, Example 53::azetidin-1-yl[3-(4-fluoro-3,5-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 53::US10669279, Example 53	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3110							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285580	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285580&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700178	378169219							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579107	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1 |(1.31,5.21,;.91,3.72,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,;-.98,1.83,;-2.46,1.44,;-.58,3.32,)|	InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	BDIWEEUPORVMSZ-UHFFFAOYSA-N	285581	US10077269, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 54::US10669279, Example 54	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 103							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700179	378169220							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579108	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1 |(1.31,5.21,;.91,3.72,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,;-.98,1.83,;-2.46,1.44,;-.58,3.32,)|	InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	BDIWEEUPORVMSZ-UHFFFAOYSA-N	285581	US10077269, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 54::US10669279, Example 54	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 107							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700179	378169220							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579109	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1 |(1.31,5.21,;.91,3.72,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,;-.98,1.83,;-2.46,1.44,;-.58,3.32,)|	InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	BDIWEEUPORVMSZ-UHFFFAOYSA-N	285581	US10077269, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 54::US10669279, Example 54	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 136							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700179	378169220							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579110	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1 |(1.31,5.21,;.91,3.72,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,;-.98,1.83,;-2.46,1.44,;-.58,3.32,)|	InChI=1S/C17H15FN4O/c1-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	BDIWEEUPORVMSZ-UHFFFAOYSA-N	285581	US10077269, Example 54::azetidin-1-yl[3-(2-fluoro-4-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 54::US10669279, Example 54	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>20000							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285581	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285581&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700179	378169220							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579111	COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	GGBSVVWNJGUOLN-UHFFFAOYSA-N	285582	US10077269, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 55::US10669279, Example 55	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 176							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700180	378169221							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579112	COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	GGBSVVWNJGUOLN-UHFFFAOYSA-N	285582	US10077269, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 55::US10669279, Example 55	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 200							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700180	378169221							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579113	COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	GGBSVVWNJGUOLN-UHFFFAOYSA-N	285582	US10077269, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 55::US10669279, Example 55	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		>1550							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700180	378169221							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579114	COc1ccc(cc1F)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H15FN4O2/c1-24-13-6-5-11(10-12(13)18)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	GGBSVVWNJGUOLN-UHFFFAOYSA-N	285582	US10077269, Example 55::azetidin-1-yl[3-(3-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 55::US10669279, Example 55	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>20900							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285582	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285582&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700180	378169221							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579115	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1 |(-2.46,1.44,;-.98,1.83,;-.58,3.32,;.91,3.72,;1.31,5.21,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,)|	InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	KDPKDOHAJHCGSZ-UHFFFAOYSA-N	285583	US10077269, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 56::US10669279, Example 56	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 22.7							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700181	378169222							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579116	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1 |(-2.46,1.44,;-.98,1.83,;-.58,3.32,;.91,3.72,;1.31,5.21,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,)|	InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	KDPKDOHAJHCGSZ-UHFFFAOYSA-N	285583	US10077269, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 56::US10669279, Example 56	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 43.1							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700181	378169222							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579117	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1 |(-2.46,1.44,;-.98,1.83,;-.58,3.32,;.91,3.72,;1.31,5.21,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,)|	InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	KDPKDOHAJHCGSZ-UHFFFAOYSA-N	285583	US10077269, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 56::US10669279, Example 56	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 84.5							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700181	378169222							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579118	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N1CCC1 |(-2.46,1.44,;-.98,1.83,;-.58,3.32,;.91,3.72,;1.31,5.21,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,)|	InChI=1S/C17H15ClN4O/c1-11-10-12(18)5-6-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	KDPKDOHAJHCGSZ-UHFFFAOYSA-N	285583	US10077269, Example 56::azetidin-1-yl[3-(4-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 56::US10669279, Example 56	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3930							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285583	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285583&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700181	378169222							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579119	Oc1ccccc1CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C21H17ClN4O2/c22-16-9-7-15(8-10-16)20-19(25-18-6-3-12-24-26(18)20)21(28)23-13-11-14-4-1-2-5-17(14)27/h1-10,12,27H,11,13H2,(H,23,28)	AQSPRZIQVZXKMZ-UHFFFAOYSA-N	285584	US10077269, Example 57::3-(4-chlorophenyl)-N-[2-(2-hydroxyphenyl)ethyl]imidazo[1,2-b]pyridazine-2-carboxamide,formate salt::US9598421, Example 57::US10669279, Example 57	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 236							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285584	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285584&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700182	378169223							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579120	Oc1ccccc1CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C21H17ClN4O2/c22-16-9-7-15(8-10-16)20-19(25-18-6-3-12-24-26(18)20)21(28)23-13-11-14-4-1-2-5-17(14)27/h1-10,12,27H,11,13H2,(H,23,28)	AQSPRZIQVZXKMZ-UHFFFAOYSA-N	285584	US10077269, Example 57::3-(4-chlorophenyl)-N-[2-(2-hydroxyphenyl)ethyl]imidazo[1,2-b]pyridazine-2-carboxamide,formate salt::US9598421, Example 57::US10669279, Example 57	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>21800							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285584	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285584&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700182	378169223							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579121	Cc1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)no1	InChI=1S/C17H12ClN5O2/c1-10-9-13(22-25-10)20-17(24)15-16(11-4-6-12(18)7-5-11)23-14(21-15)3-2-8-19-23/h2-9H,1H3,(H,20,22,24)	WFHCBSIMFWEHOP-UHFFFAOYSA-N	285585	US10077269, Example 58::3-(4-chlorophenyl)-N-(5-methyl-1,2-oxazol-3-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US9598421, Example 58::US10669279, Example 58	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 43.3							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285585	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285585&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700183	378169224							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579122	Cc1cc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)no1	InChI=1S/C17H12ClN5O2/c1-10-9-13(22-25-10)20-17(24)15-16(11-4-6-12(18)7-5-11)23-14(21-15)3-2-8-19-23/h2-9H,1H3,(H,20,22,24)	WFHCBSIMFWEHOP-UHFFFAOYSA-N	285585	US10077269, Example 58::3-(4-chlorophenyl)-N-(5-methyl-1,2-oxazol-3-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US9598421, Example 58::US10669279, Example 58	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 831							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285585	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285585&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700183	378169224							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579123	Cn1ncc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)n1	InChI=1S/C16H12ClN7O/c1-23-19-9-12(22-23)20-16(25)14-15(10-4-6-11(17)7-5-10)24-13(21-14)3-2-8-18-24/h2-9H,1H3,(H,20,22,25)	KUCAVVPPPHKSFZ-UHFFFAOYSA-N	285586	US10077269, Example 59::3-(4-chlorophenyl)-N-(2-methyl-2H-1,2,3-triazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US9598421, Example 59::US10669279, Example 59	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 58.5							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285586	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285586&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700184	378169225							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579124	Cn1ncc(NC(=O)c2nc3cccnn3c2-c2ccc(Cl)cc2)n1	InChI=1S/C16H12ClN7O/c1-23-19-9-12(22-23)20-16(25)14-15(10-4-6-11(17)7-5-10)24-13(21-14)3-2-8-18-24/h2-9H,1H3,(H,20,22,25)	KUCAVVPPPHKSFZ-UHFFFAOYSA-N	285586	US10077269, Example 59::3-(4-chlorophenyl)-N-(2-methyl-2H-1,2,3-triazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide,trifluoroacetate salt::US9598421, Example 59::US10669279, Example 59	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 749							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285586	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285586&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700184	378169225							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579125	FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2	LLONFBHYVKPZCK-UHFFFAOYSA-N	285587	US10077269, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone::US9598421, Example 60::US10669279, Example 60	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 269							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700185	378169226							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579126	FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2	LLONFBHYVKPZCK-UHFFFAOYSA-N	285587	US10077269, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone::US9598421, Example 60::US10669279, Example 60	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 196							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700185	378169226							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579127	FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2	LLONFBHYVKPZCK-UHFFFAOYSA-N	285587	US10077269, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone::US9598421, Example 60::US10669279, Example 60	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 287							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700185	378169226							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579128	FC1CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H12ClFN4O/c17-11-5-3-10(4-6-11)15-14(16(23)21-8-12(18)9-21)20-13-2-1-7-19-22(13)15/h1-7,12H,8-9H2	LLONFBHYVKPZCK-UHFFFAOYSA-N	285587	US10077269, Example 60::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3-fluoroazetidin-1-yl)methanone::US9598421, Example 60::US10669279, Example 60	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>4930							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285587	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285587&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700185	378169226							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579129	FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2	PKGAXGNVVMHTJZ-UHFFFAOYSA-N	285588	US10077269, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone::US9598421, Example 61::US10669279, Example 61	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 144							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700186	378169227							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579130	FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2	PKGAXGNVVMHTJZ-UHFFFAOYSA-N	285588	US10077269, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone::US9598421, Example 61::US10669279, Example 61	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 184							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700186	378169227							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579131	FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2	PKGAXGNVVMHTJZ-UHFFFAOYSA-N	285588	US10077269, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone::US9598421, Example 61::US10669279, Example 61	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 126							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700186	378169227							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579132	FC1(F)CN(C1)C(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C16H11ClF2N4O/c17-11-5-3-10(4-6-11)14-13(15(24)22-8-16(18,19)9-22)21-12-2-1-7-20-23(12)14/h1-7H,8-9H2	PKGAXGNVVMHTJZ-UHFFFAOYSA-N	285588	US10077269, Example 61::[3-(4-chlorophenyl)imidazo[1,2-b]pyridazin-2-yl](3,3-di-fluoroazetidin-1-yl)methanone::US9598421, Example 61::US10669279, Example 61	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 1930							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285588	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285588&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700186	378169227							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579133	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2nccnc2c1	InChI=1S/C18H14N6O/c25-18(23-9-2-10-23)16-17(24-15(22-16)3-1-6-21-24)12-4-5-13-14(11-12)20-8-7-19-13/h1,3-8,11H,2,9-10H2	BGLGXXOVOLTBJL-UHFFFAOYSA-N	285589	US10077269, Example 62::azetidin-1-yl[3-(quinoxalin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone, formate salt::US9598421, Example 62::US10669279, Example 62	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 275							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285589	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285589&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700187	378169228							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579134	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2nccnc2c1	InChI=1S/C18H14N6O/c25-18(23-9-2-10-23)16-17(24-15(22-16)3-1-6-21-24)12-4-5-13-14(11-12)20-8-7-19-13/h1,3-8,11H,2,9-10H2	BGLGXXOVOLTBJL-UHFFFAOYSA-N	285589	US10077269, Example 62::azetidin-1-yl[3-(quinoxalin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone, formate salt::US9598421, Example 62::US10669279, Example 62	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 11000							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285589	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285589&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700187	378169228							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579135	CC(=O)c1ccc(F)c(c1)-c1c(nc2cccnn12)C(=O)N1CCC1 |(4.5,2.98,;3.41,4.07,;3.81,5.55,;1.92,3.67,;.83,4.76,;-.66,4.36,;-1.06,2.87,;-2.54,2.47,;.03,1.78,;1.52,2.18,;-.36,.29,;.54,-.95,;-.36,-2.2,;-1.83,-1.72,;-3.16,-2.49,;-4.5,-1.72,;-4.5,-.18,;-3.16,.59,;-1.83,-.18,;2.08,-.95,;2.85,.38,;2.85,-2.29,;2.45,-3.77,;3.94,-4.17,;4.34,-2.68,)|	InChI=1S/C18H15FN4O2/c1-11(24)12-5-6-14(19)13(10-12)17-16(18(25)22-8-3-9-22)21-15-4-2-7-20-23(15)17/h2,4-7,10H,3,8-9H2,1H3	QERGAMABSQIOLR-UHFFFAOYSA-N	285590	US10077269, Example 63::1-{3-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-4-fluoro-phenyl}ethanone, formate salt::US9598421, Example 63::US10669279, Example 63	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 17.7							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285590	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285590&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875365	378169229							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579136	CC(=O)c1ccc(F)c(c1)-c1c(nc2cccnn12)C(=O)N1CCC1 |(4.5,2.98,;3.41,4.07,;3.81,5.55,;1.92,3.67,;.83,4.76,;-.66,4.36,;-1.06,2.87,;-2.54,2.47,;.03,1.78,;1.52,2.18,;-.36,.29,;.54,-.95,;-.36,-2.2,;-1.83,-1.72,;-3.16,-2.49,;-4.5,-1.72,;-4.5,-.18,;-3.16,.59,;-1.83,-.18,;2.08,-.95,;2.85,.38,;2.85,-2.29,;2.45,-3.77,;3.94,-4.17,;4.34,-2.68,)|	InChI=1S/C18H15FN4O2/c1-11(24)12-5-6-14(19)13(10-12)17-16(18(25)22-8-3-9-22)21-15-4-2-7-20-23(15)17/h2,4-7,10H,3,8-9H2,1H3	QERGAMABSQIOLR-UHFFFAOYSA-N	285590	US10077269, Example 63::1-{3-[2-(azetidin-1-ylcarbonyl)imidazo[1,2-b]pyridazin-3-yl]-4-fluoro-phenyl}ethanone, formate salt::US9598421, Example 63::US10669279, Example 63	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 394							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285590	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285590&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875365	378169229							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579137	Cc1ccc(Cl)cc1-c1c(nc2cccnn12)C(=O)N1CCC1 |(-2.46,2.18,;-.98,2.58,;-.58,4.07,;.91,4.46,;2,3.38,;3.49,3.77,;1.6,1.89,;.11,1.49,;-.29,0,;.62,-1.24,;-.29,-2.49,;-1.75,-2.01,;-3.08,-2.78,;-4.42,-2.01,;-4.42,-.47,;-3.08,.3,;-1.75,-.47,;2.16,-1.24,;2.93,.09,;2.93,-2.58,;2.53,-4.07,;4.02,-4.46,;4.42,-2.98,)|	InChI=1S/C17H15ClN4O/c1-11-5-6-12(18)10-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	COVWSPFRFUFHGD-UHFFFAOYSA-N	285591	US10077269, Example 64::azetidin-1-yl[3-(5-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 64::US10669279, Example 64	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 24.2							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285591	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285591&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700189	378169230							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579138	Cc1ccc(Cl)cc1-c1c(nc2cccnn12)C(=O)N1CCC1 |(-2.46,2.18,;-.98,2.58,;-.58,4.07,;.91,4.46,;2,3.38,;3.49,3.77,;1.6,1.89,;.11,1.49,;-.29,0,;.62,-1.24,;-.29,-2.49,;-1.75,-2.01,;-3.08,-2.78,;-4.42,-2.01,;-4.42,-.47,;-3.08,.3,;-1.75,-.47,;2.16,-1.24,;2.93,.09,;2.93,-2.58,;2.53,-4.07,;4.02,-4.46,;4.42,-2.98,)|	InChI=1S/C17H15ClN4O/c1-11-5-6-12(18)10-13(11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	COVWSPFRFUFHGD-UHFFFAOYSA-N	285591	US10077269, Example 64::azetidin-1-yl[3-(5-chloro-2-methylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 64::US10669279, Example 64	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 844							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285591	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285591&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700189	378169230							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579139	Clc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(Cl)c1 |(1.31,5.21,;.91,3.72,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,;-.98,1.83,;-2.46,1.44,;-.58,3.32,)|	InChI=1S/C16H12Cl2N4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	HDPIQIDAUQGIBP-UHFFFAOYSA-N	285592	US10077269, Example 65::azetidin-1-yl[3-(2,4-dichlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 65::US10669279, Example 65	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 71.9							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285592	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285592&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700188	378169231							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579140	Clc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(Cl)c1 |(1.31,5.21,;.91,3.72,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,;-.98,1.83,;-2.46,1.44,;-.58,3.32,)|	InChI=1S/C16H12Cl2N4O/c17-10-4-5-11(12(18)9-10)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	HDPIQIDAUQGIBP-UHFFFAOYSA-N	285592	US10077269, Example 65::azetidin-1-yl[3-(2,4-dichlorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 65::US10669279, Example 65	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3720							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285592	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285592&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700188	378169231							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579141	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(C)c1Cl |(1.31,5.66,;.91,4.18,;2,3.09,;1.6,1.6,;.11,1.2,;-.29,-.29,;.62,-1.53,;-.29,-2.78,;-1.75,-2.3,;-3.08,-3.07,;-4.42,-2.3,;-4.42,-.76,;-3.08,.01,;-1.75,-.76,;2.16,-1.53,;2.93,-.2,;2.93,-2.86,;2.53,-4.35,;4.02,-4.75,;4.42,-3.26,;-.98,2.29,;-2.46,1.89,;-.58,3.78,;-1.67,4.87,)|	InChI=1S/C18H17ClN4O/c1-11-6-7-13(12(2)15(11)19)17-16(18(24)22-9-4-10-22)21-14-5-3-8-20-23(14)17/h3,5-8H,4,9-10H2,1-2H3	FQEXMVRMBJXJHA-UHFFFAOYSA-N	285593	US10077269, Example 66::azetidin-1-yl[3-(3-chloro-2,4-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt::US9598421, Example 66::US10669279, Example 66	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 41.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285593	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285593&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700190	378169232							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579142	Cc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(C)c1Cl |(1.31,5.66,;.91,4.18,;2,3.09,;1.6,1.6,;.11,1.2,;-.29,-.29,;.62,-1.53,;-.29,-2.78,;-1.75,-2.3,;-3.08,-3.07,;-4.42,-2.3,;-4.42,-.76,;-3.08,.01,;-1.75,-.76,;2.16,-1.53,;2.93,-.2,;2.93,-2.86,;2.53,-4.35,;4.02,-4.75,;4.42,-3.26,;-.98,2.29,;-2.46,1.89,;-.58,3.78,;-1.67,4.87,)|	InChI=1S/C18H17ClN4O/c1-11-6-7-13(12(2)15(11)19)17-16(18(24)22-9-4-10-22)21-14-5-3-8-20-23(14)17/h3,5-8H,4,9-10H2,1-2H3	FQEXMVRMBJXJHA-UHFFFAOYSA-N	285593	US10077269, Example 66::azetidin-1-yl[3-(3-chloro-2,4-dimethylphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt::US9598421, Example 66::US10669279, Example 66	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3390							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285593	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285593&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700190	378169232							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579143	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCOc2c1	InChI=1S/C18H16N4O3/c23-18(21-7-2-8-21)16-17(22-15(20-16)3-1-6-19-22)12-4-5-13-14(11-12)25-10-9-24-13/h1,3-6,11H,2,7-10H2	KQJWGLFCGGXBHN-UHFFFAOYSA-N	285594	US10077269, Example 67::azetidin-1-yl[3-(2,3-dihydro-1,4-benzodioxin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt::US9598421, Example 67::US10669279, Example 67	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 59.8							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285594	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285594&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875392	378169233							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579144	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2OCCOc2c1	InChI=1S/C18H16N4O3/c23-18(21-7-2-8-21)16-17(22-15(20-16)3-1-6-19-22)12-4-5-13-14(11-12)25-10-9-24-13/h1,3-6,11H,2,7-10H2	KQJWGLFCGGXBHN-UHFFFAOYSA-N	285594	US10077269, Example 67::azetidin-1-yl[3-(2,3-dihydro-1,4-benzodioxin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone,formate salt::US9598421, Example 67::US10669279, Example 67	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2260							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285594	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285594&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875392	378169233							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579145	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F |r,wU:3.4,1.0,(5.5,-1.78,;4.73,-3.11,;4.73,-4.65,;3.39,-3.88,;1.85,-3.88,;1.08,-2.55,;1.85,-1.21,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;-1.36,-1.3,;-.96,.19,;.52,.59,;.92,2.07,;-.17,3.16,;.23,4.65,;-1.66,2.76,;-2.05,1.28,;-3.54,.88,)|	InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)	OPBIZTGCIJZSGG-UHFFFAOYSA-N	285595	US10077269, Example 68::3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 68::US10669279, Example 68	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 10.6							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700194	378169234							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579146	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F |r,wU:3.4,1.0,(5.5,-1.78,;4.73,-3.11,;4.73,-4.65,;3.39,-3.88,;1.85,-3.88,;1.08,-2.55,;1.85,-1.21,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;-1.36,-1.3,;-.96,.19,;.52,.59,;.92,2.07,;-.17,3.16,;.23,4.65,;-1.66,2.76,;-2.05,1.28,;-3.54,.88,)|	InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)	OPBIZTGCIJZSGG-UHFFFAOYSA-N	285595	US10077269, Example 68::3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 68::US10669279, Example 68	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 35.4							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700194	378169234							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579147	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F |r,wU:3.4,1.0,(5.5,-1.78,;4.73,-3.11,;4.73,-4.65,;3.39,-3.88,;1.85,-3.88,;1.08,-2.55,;1.85,-1.21,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;-1.36,-1.3,;-.96,.19,;.52,.59,;.92,2.07,;-.17,3.16,;.23,4.65,;-1.66,2.76,;-2.05,1.28,;-3.54,.88,)|	InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)	OPBIZTGCIJZSGG-UHFFFAOYSA-N	285595	US10077269, Example 68::3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 68::US10669279, Example 68	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 25.1							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700194	378169234							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579148	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1F |r,wU:3.4,1.0,(5.5,-1.78,;4.73,-3.11,;4.73,-4.65,;3.39,-3.88,;1.85,-3.88,;1.08,-2.55,;1.85,-1.21,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;-1.36,-1.3,;-.96,.19,;.52,.59,;.92,2.07,;-.17,3.16,;.23,4.65,;-1.66,2.76,;-2.05,1.28,;-3.54,.88,)|	InChI=1S/C16H11ClF2N4O/c17-8-3-4-9(10(18)6-8)15-14(16(24)21-12-7-11(12)19)22-13-2-1-5-20-23(13)15/h1-6,11-12H,7H2,(H,21,24)	OPBIZTGCIJZSGG-UHFFFAOYSA-N	285595	US10077269, Example 68::3-(4-chloro-2-fluorophenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 68::US10669279, Example 68	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2620							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285595	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285595&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700194	378169234							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579149	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1 |r|	InChI=1S/C15H11ClFN5O/c16-9-4-8(6-18-7-9)14-13(15(23)20-11-5-10(11)17)21-12-2-1-3-19-22(12)14/h1-4,6-7,10-11H,5H2,(H,20,23)	ZHXHNZIKCBDMKP-UHFFFAOYSA-N	285596	US10077269, Example 69::3-(5-chloropyridin-3-yl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 69::US10669279, Example 69	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 116							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285596	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285596&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700193	378169235							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579150	F[C@H]1C[C@H]1NC(=O)c1nc2cccnn2c1-c1cncc(Cl)c1 |r|	InChI=1S/C15H11ClFN5O/c16-9-4-8(6-18-7-9)14-13(15(23)20-11-5-10(11)17)21-12-2-1-3-19-22(12)14/h1-4,6-7,10-11H,5H2,(H,20,23)	ZHXHNZIKCBDMKP-UHFFFAOYSA-N	285596	US10077269, Example 69::3-(5-chloropyridin-3-yl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 69::US10669279, Example 69	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3330							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285596	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285596&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700193	378169235							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579151	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r,wU:20.22,22.26,(-3.54,.88,;-2.05,1.28,;-1.66,2.76,;-.17,3.16,;.23,4.65,;.92,2.07,;.52,.59,;-.96,.19,;-1.36,-1.3,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;1.08,-2.55,;1.85,-1.21,;1.85,-3.88,;3.39,-3.88,;4.73,-4.65,;4.73,-3.11,;5.5,-1.78,)|	InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)	XIVVDTJZCTVMFP-UHFFFAOYSA-N	285597	US10077269, Example 70::3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 70::US10669279, Example 70	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 36.4							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700199	378169236							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579152	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r,wU:20.22,22.26,(-3.54,.88,;-2.05,1.28,;-1.66,2.76,;-.17,3.16,;.23,4.65,;.92,2.07,;.52,.59,;-.96,.19,;-1.36,-1.3,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;1.08,-2.55,;1.85,-1.21,;1.85,-3.88,;3.39,-3.88,;4.73,-4.65,;4.73,-3.11,;5.5,-1.78,)|	InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)	XIVVDTJZCTVMFP-UHFFFAOYSA-N	285597	US10077269, Example 70::3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 70::US10669279, Example 70	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 31.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700199	378169236							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579153	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r,wU:20.22,22.26,(-3.54,.88,;-2.05,1.28,;-1.66,2.76,;-.17,3.16,;.23,4.65,;.92,2.07,;.52,.59,;-.96,.19,;-1.36,-1.3,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;1.08,-2.55,;1.85,-1.21,;1.85,-3.88,;3.39,-3.88,;4.73,-4.65,;4.73,-3.11,;5.5,-1.78,)|	InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)	XIVVDTJZCTVMFP-UHFFFAOYSA-N	285597	US10077269, Example 70::3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 70::US10669279, Example 70	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 90.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700199	378169236							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579154	Cc1cc(Cl)ccc1-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r,wU:20.22,22.26,(-3.54,.88,;-2.05,1.28,;-1.66,2.76,;-.17,3.16,;.23,4.65,;.92,2.07,;.52,.59,;-.96,.19,;-1.36,-1.3,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;1.08,-2.55,;1.85,-1.21,;1.85,-3.88,;3.39,-3.88,;4.73,-4.65,;4.73,-3.11,;5.5,-1.78,)|	InChI=1S/C17H14ClFN4O/c1-9-7-10(18)4-5-11(9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)	XIVVDTJZCTVMFP-UHFFFAOYSA-N	285597	US10077269, Example 70::3-(4-chloro-2-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 70::US10669279, Example 70	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 5760							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285597	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285597&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700199	378169236							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579155	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r|	InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)	GAGSQLMTGCAMOG-UHFFFAOYSA-N	285598	US10077269, Example 71::3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 71::US10669279, Example 71	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		<0.669							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700196	378169237							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579156	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r|	InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)	GAGSQLMTGCAMOG-UHFFFAOYSA-N	285598	US10077269, Example 71::3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 71::US10669279, Example 71	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 2.82							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700196	378169237							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579157	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r|	InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)	GAGSQLMTGCAMOG-UHFFFAOYSA-N	285598	US10077269, Example 71::3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 71::US10669279, Example 71	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 2.00							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700196	378169237							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579158	Cc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N[C@@H]1C[C@@H]1F |r|	InChI=1S/C17H14ClFN4O/c1-9-4-5-10(7-11(9)18)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)	GAGSQLMTGCAMOG-UHFFFAOYSA-N	285598	US10077269, Example 71::3-(3-chloro-4-methylphenyl)-N-[(1R,2S)-2-fluorocyclopro-pyl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 71::US10669279, Example 71	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 113							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285598	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285598&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700196	378169237							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579159	Cc1ccc(-c2c(nc3cccnn23)C(=O)N[C@@H]2C[C@@H]2F)c(F)c1 |r,wU:17.18,19.22,(.23,4.65,;-.17,3.16,;.92,2.07,;.52,.59,;-.96,.19,;-1.36,-1.3,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;1.08,-2.55,;1.85,-1.21,;1.85,-3.88,;3.39,-3.88,;4.73,-4.65,;4.73,-3.11,;5.5,-1.78,;-2.05,1.28,;-3.54,.88,;-1.66,2.76,)|	InChI=1S/C17H14F2N4O/c1-9-4-5-10(11(18)7-9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)	LTEXTCILPHUJPK-UHFFFAOYSA-N	285599	US10077269, Example 72::N-[(1R,2S)-2-fluorocyclopro-pyl]-3-(2-fluoro-4-methyl-phenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 72::US10669279, Example 72	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 192							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285599	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285599&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700195	378169238							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579160	Cc1ccc(-c2c(nc3cccnn23)C(=O)N[C@@H]2C[C@@H]2F)c(F)c1 |r,wU:17.18,19.22,(.23,4.65,;-.17,3.16,;.92,2.07,;.52,.59,;-.96,.19,;-1.36,-1.3,;-.46,-2.55,;-1.36,-3.79,;-2.83,-3.32,;-4.16,-4.09,;-5.5,-3.32,;-5.5,-1.78,;-4.16,-1.01,;-2.83,-1.78,;1.08,-2.55,;1.85,-1.21,;1.85,-3.88,;3.39,-3.88,;4.73,-4.65,;4.73,-3.11,;5.5,-1.78,;-2.05,1.28,;-3.54,.88,;-1.66,2.76,)|	InChI=1S/C17H14F2N4O/c1-9-4-5-10(11(18)7-9)16-15(17(24)21-13-8-12(13)19)22-14-3-2-6-20-23(14)16/h2-7,12-13H,8H2,1H3,(H,21,24)	LTEXTCILPHUJPK-UHFFFAOYSA-N	285599	US10077269, Example 72::N-[(1R,2S)-2-fluorocyclopro-pyl]-3-(2-fluoro-4-methyl-phenyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 72::US10669279, Example 72	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 6590							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285599	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285599&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700195	378169238							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579161	COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1 |(2.8,5.41,;1.31,5.01,;.91,3.52,;2,2.43,;1.6,.94,;.11,.55,;-.29,-.94,;.62,-2.19,;-.29,-3.43,;-1.75,-2.96,;-3.08,-3.73,;-4.42,-2.96,;-4.42,-1.42,;-3.08,-.65,;-1.75,-1.42,;2.16,-2.19,;2.93,-.85,;2.93,-3.52,;2.53,-5.01,;4.02,-5.41,;4.42,-3.92,;-.98,1.64,;-2.46,1.24,;-.58,3.12,)|	InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	WXZZRVFNPNQGRD-UHFFFAOYSA-N	285600	US10077269, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 73::US10669279, Example 73	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 165							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700197	378169239							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579162	COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1 |(2.8,5.41,;1.31,5.01,;.91,3.52,;2,2.43,;1.6,.94,;.11,.55,;-.29,-.94,;.62,-2.19,;-.29,-3.43,;-1.75,-2.96,;-3.08,-3.73,;-4.42,-2.96,;-4.42,-1.42,;-3.08,-.65,;-1.75,-1.42,;2.16,-2.19,;2.93,-.85,;2.93,-3.52,;2.53,-5.01,;4.02,-5.41,;4.42,-3.92,;-.98,1.64,;-2.46,1.24,;-.58,3.12,)|	InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	WXZZRVFNPNQGRD-UHFFFAOYSA-N	285600	US10077269, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 73::US10669279, Example 73	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 495							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700197	378169239							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579163	COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1 |(2.8,5.41,;1.31,5.01,;.91,3.52,;2,2.43,;1.6,.94,;.11,.55,;-.29,-.94,;.62,-2.19,;-.29,-3.43,;-1.75,-2.96,;-3.08,-3.73,;-4.42,-2.96,;-4.42,-1.42,;-3.08,-.65,;-1.75,-1.42,;2.16,-2.19,;2.93,-.85,;2.93,-3.52,;2.53,-5.01,;4.02,-5.41,;4.42,-3.92,;-.98,1.64,;-2.46,1.24,;-.58,3.12,)|	InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	WXZZRVFNPNQGRD-UHFFFAOYSA-N	285600	US10077269, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 73::US10669279, Example 73	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 1440							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700197	378169239							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579164	COc1ccc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)c1 |(2.8,5.41,;1.31,5.01,;.91,3.52,;2,2.43,;1.6,.94,;.11,.55,;-.29,-.94,;.62,-2.19,;-.29,-3.43,;-1.75,-2.96,;-3.08,-3.73,;-4.42,-2.96,;-4.42,-1.42,;-3.08,-.65,;-1.75,-1.42,;2.16,-2.19,;2.93,-.85,;2.93,-3.52,;2.53,-5.01,;4.02,-5.41,;4.42,-3.92,;-.98,1.64,;-2.46,1.24,;-.58,3.12,)|	InChI=1S/C17H15FN4O2/c1-24-11-5-6-12(13(18)10-11)16-15(17(23)21-8-3-9-21)20-14-4-2-7-19-22(14)16/h2,4-7,10H,3,8-9H2,1H3	WXZZRVFNPNQGRD-UHFFFAOYSA-N	285600	US10077269, Example 73::azetidin-1-yl[3-(2-fluoro-4-methoxyphenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 73::US10669279, Example 73	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>24700							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285600	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285600&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700197	378169239							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579165	O=C(N1CCC1)c1nc2cccnn2c1-c1cnc2ccnn2c1	InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-5-19-23)11-9-17-12-4-6-18-22(12)10-11/h1,3-6,9-10H,2,7-8H2	RINAWWCARFNGLM-UHFFFAOYSA-N	285601	US10077269, Example 74::azetidin-1-yl[3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 74::US10669279, Example 74	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 225							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285601	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285601&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700198	378169240							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579166	O=C(N1CCC1)c1nc2cccnn2c1-c1cnc2ccnn2c1	InChI=1S/C16H13N7O/c24-16(21-7-2-8-21)14-15(23-13(20-14)3-1-5-19-23)11-9-17-12-4-6-18-22(12)10-11/h1,3-6,9-10H,2,7-8H2	RINAWWCARFNGLM-UHFFFAOYSA-N	285601	US10077269, Example 74::azetidin-1-yl[3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 74::US10669279, Example 74	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 10500							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285601	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285601&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700198	378169240							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579167	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24)	DSCLXJMGAQHPPO-UHFFFAOYSA-N	285602	US10077269, Example 75::N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 75::US10669279, Example 75	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 10.5							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875376	378169241							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579168	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24)	DSCLXJMGAQHPPO-UHFFFAOYSA-N	285602	US10077269, Example 75::N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 75::US10669279, Example 75	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 5.99							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875376	378169241							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579169	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24)	DSCLXJMGAQHPPO-UHFFFAOYSA-N	285602	US10077269, Example 75::N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 75::US10669279, Example 75	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 24.9							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875376	378169241							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579170	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-8-9(5-7-19-12)14-13(15(24)21-10-3-4-10)22-11-2-1-6-20-23(11)14/h1-2,5-8,10,16H,3-4H2,(H,21,24)	DSCLXJMGAQHPPO-UHFFFAOYSA-N	285602	US10077269, Example 75::N-cyclopropyl-3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 75::US10669279, Example 75	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 104							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285602	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285602&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875376	378169241							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579171	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2	FGLJIZXIRLUUJT-UHFFFAOYSA-N	285603	US10077269, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone::US9598421, Example 76::US10669279, Example 76	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 7.09							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875361	378169242							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579172	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2	FGLJIZXIRLUUJT-UHFFFAOYSA-N	285603	US10077269, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone::US9598421, Example 76::US10669279, Example 76	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 5.43							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875361	378169242							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579173	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2	FGLJIZXIRLUUJT-UHFFFAOYSA-N	285603	US10077269, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone::US9598421, Example 76::US10669279, Example 76	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 22.2							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875361	378169242							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579174	FC(F)Oc1cc(ccn1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-9-10(4-6-19-12)14-13(15(24)22-7-2-8-22)21-11-3-1-5-20-23(11)14/h1,3-6,9,16H,2,7-8H2	FGLJIZXIRLUUJT-UHFFFAOYSA-N	285603	US10077269, Example 76::azetidin-1-yl{3-[2-(difluoro-methoxy)pyridin-4-yl]imidazo[1,2-b]pyridazin-2-yl}methanone::US9598421, Example 76::US10669279, Example 76	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 94.5							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285603	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285603&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875361	378169242							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579175	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2	AZGFYUPSXODBAO-UHFFFAOYSA-N	285607	US10077269, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 77::US10669279, Example 77	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 46.1							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700200	378169246							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579176	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2	AZGFYUPSXODBAO-UHFFFAOYSA-N	285607	US10077269, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 77::US10669279, Example 77	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 80.4							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700200	378169246							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579177	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2	AZGFYUPSXODBAO-UHFFFAOYSA-N	285607	US10077269, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 77::US10669279, Example 77	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 186							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700200	378169246							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579178	O=C(N1CCC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(21-7-2-8-21)15-16(22-14(20-15)3-1-6-19-22)11-4-5-12-13(9-11)24-10-18-12/h1,3-6,9-10H,2,7-8H2	AZGFYUPSXODBAO-UHFFFAOYSA-N	285607	US10077269, Example 77::azetidin-1-yl[3-(1,3-ben-zoxazol-6-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 77::US10669279, Example 77	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>16600							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285607	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285607&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700200	378169246							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579179	O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-3-4-11)14-15(23-13(21-14)2-1-6-19-23)10-8-17-12-5-7-18-22(12)9-10/h1-2,5-9,11H,3-4H2,(H,20,24)	CWHUSRYDJYDLGV-UHFFFAOYSA-N	285608	US10077269, Example 78::N-cyclopropyl-3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 78::US10669279, Example 78	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 364							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285608	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285608&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875395	378169247							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579180	O=C(NC1CC1)c1nc2cccnn2c1-c1cnc2ccnn2c1	InChI=1S/C16H13N7O/c24-16(20-11-3-4-11)14-15(23-13(21-14)2-1-6-19-23)10-8-17-12-5-7-18-22(12)9-10/h1-2,5-9,11H,3-4H2,(H,20,24)	CWHUSRYDJYDLGV-UHFFFAOYSA-N	285608	US10077269, Example 78::N-cyclopropyl-3-(pyrazolo[1,5-a]pyrimidin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 78::US10669279, Example 78	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 6490							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285608	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285608&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875395	378169247							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579181	Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N |(-3.16,.13,;-1.67,.53,;-1.27,2.02,;.21,2.51,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24)	NOSXOAFVJDFCQR-UHFFFAOYSA-N	285609	US10077269, Example 79::3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 79::US10669279, Example 79	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 48.8							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875362	378169248							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579182	Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N |(-3.16,.13,;-1.67,.53,;-1.27,2.02,;.21,2.51,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24)	NOSXOAFVJDFCQR-UHFFFAOYSA-N	285609	US10077269, Example 79::3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 79::US10669279, Example 79	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 190							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875362	378169248							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579183	Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N |(-3.16,.13,;-1.67,.53,;-1.27,2.02,;.21,2.51,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24)	NOSXOAFVJDFCQR-UHFFFAOYSA-N	285609	US10077269, Example 79::3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 79::US10669279, Example 79	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 297							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875362	378169248							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579184	Fc1cc(ccc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N |(-3.16,.13,;-1.67,.53,;-1.27,2.02,;.21,2.51,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H12FN5O/c18-13-8-10(9-19)3-6-12(13)16-15(17(24)21-11-4-5-11)22-14-2-1-7-20-23(14)16/h1-3,6-8,11H,4-5H2,(H,21,24)	NOSXOAFVJDFCQR-UHFFFAOYSA-N	285609	US10077269, Example 79::3-(4-cyano-2-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 79::US10669279, Example 79	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>25400							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285609	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285609&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875362	378169248							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579185	Cc1ccc(cc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N |(-3.16,1.62,;-1.67,2.02,;-1.27,3.51,;.22,3.91,;1.43,2.84,;.91,1.33,;-.58,.93,;-.98,-.56,;-.07,-1.8,;-.98,-3.05,;-2.44,-2.57,;-3.78,-3.34,;-5.11,-2.57,;-5.11,-1.03,;-3.78,-.26,;-2.44,-1.03,;1.47,-1.8,;2.24,-.47,;2.24,-3.14,;3.78,-3.14,;5.11,-3.91,;5.11,-2.37,;2.92,3.23,;4.41,3.63,)|	InChI=1S/C18H15N5O/c1-11-4-5-12(10-19)9-14(11)17-16(18(24)21-13-6-7-13)22-15-3-2-8-20-23(15)17/h2-5,8-9,13H,6-7H2,1H3,(H,21,24)	AYAPJFYFCDHLKN-UHFFFAOYSA-N	285610	US10077269, Example 80::3-(5-cyano-2-methylphenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 80::US10669279, Example 80	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 344							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285610	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285610&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875393	378169249							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579186	Cc1ccc(cc1-c1c(nc2cccnn12)C(=O)NC1CC1)C#N |(-3.16,1.62,;-1.67,2.02,;-1.27,3.51,;.22,3.91,;1.43,2.84,;.91,1.33,;-.58,.93,;-.98,-.56,;-.07,-1.8,;-.98,-3.05,;-2.44,-2.57,;-3.78,-3.34,;-5.11,-2.57,;-5.11,-1.03,;-3.78,-.26,;-2.44,-1.03,;1.47,-1.8,;2.24,-.47,;2.24,-3.14,;3.78,-3.14,;5.11,-3.91,;5.11,-2.37,;2.92,3.23,;4.41,3.63,)|	InChI=1S/C18H15N5O/c1-11-4-5-12(10-19)9-14(11)17-16(18(24)21-13-6-7-13)22-15-3-2-8-20-23(15)17/h2-5,8-9,13H,6-7H2,1H3,(H,21,24)	AYAPJFYFCDHLKN-UHFFFAOYSA-N	285610	US10077269, Example 80::3-(5-cyano-2-methylphenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 80::US10669279, Example 80	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>25400							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285610	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285610&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875393	378169249							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579187	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22)	KMAXAJFXSIHYPS-UHFFFAOYSA-N	285611	US10077269, Example 81::3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 81::US10669279, Example 81	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 7.86							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875415	378169250							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579188	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22)	KMAXAJFXSIHYPS-UHFFFAOYSA-N	285611	US10077269, Example 81::3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 81::US10669279, Example 81	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 9.34							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875415	378169250							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579189	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22)	KMAXAJFXSIHYPS-UHFFFAOYSA-N	285611	US10077269, Example 81::3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 81::US10669279, Example 81	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 25.8							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875415	378169250							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579190	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C15H12ClFN4O/c1-2-18-15(22)13-14(9-5-6-10(16)11(17)8-9)21-12(20-13)4-3-7-19-21/h3-8H,2H2,1H3,(H,18,22)	KMAXAJFXSIHYPS-UHFFFAOYSA-N	285611	US10077269, Example 81::3-(4-chloro-3-fluorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 81::US10669279, Example 81	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 853							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285611	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285611&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875415	378169250							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579191	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1	InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25)	YEUSBANVZAFKBV-UHFFFAOYSA-N	285612	US10077269, Example 82::3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 82::US10669279, Example 82	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 12.0							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875379	378169251							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579192	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1	InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25)	YEUSBANVZAFKBV-UHFFFAOYSA-N	285612	US10077269, Example 82::3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 82::US10669279, Example 82	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 5.14							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875379	378169251							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579193	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1	InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25)	YEUSBANVZAFKBV-UHFFFAOYSA-N	285612	US10077269, Example 82::3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 82::US10669279, Example 82	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 43.4							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875379	378169251							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579194	Fc1cc(ccc1Cl)-c1c(nc2cccnn12)C(=O)Nc1cn[nH]c1	InChI=1S/C16H10ClFN6O/c17-11-4-3-9(6-12(11)18)15-14(16(25)22-10-7-19-20-8-10)23-13-2-1-5-21-24(13)15/h1-8H,(H,19,20)(H,22,25)	YEUSBANVZAFKBV-UHFFFAOYSA-N	285612	US10077269, Example 82::3-(4-chloro-3-fluorophenyl)-N-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 82::US10669279, Example 82	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 56.5							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285612	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285612&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875379	378169251							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579195	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	VGRIHMHLBGLHHB-UHFFFAOYSA-N	285613	US10077269, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 83::US10669279, Example 83	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 6.21							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			125474324	378169252							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579196	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	VGRIHMHLBGLHHB-UHFFFAOYSA-N	285613	US10077269, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 83::US10669279, Example 83	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 5.39							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			125474324	378169252							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579197	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	VGRIHMHLBGLHHB-UHFFFAOYSA-N	285613	US10077269, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 83::US10669279, Example 83	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 40.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			125474324	378169252							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579198	Clc1ccc(cc1Cl)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H12Cl2N4O/c17-11-5-4-10(9-12(11)18)15-14(16(23)21-7-2-8-21)20-13-3-1-6-19-22(13)15/h1,3-6,9H,2,7-8H2	VGRIHMHLBGLHHB-UHFFFAOYSA-N	285613	US10077269, Example 83::azetidin-1-yl[3-(3,4-dichloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 83::US10669279, Example 83	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 495							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285613	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285613&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			125474324	378169252							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579199	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2	LLKDXLOAXVIBRW-UHFFFAOYSA-N	285614	US10077269, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 84::US10669279, Example 84	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 16.7							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875397	378169253							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579200	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2	LLKDXLOAXVIBRW-UHFFFAOYSA-N	285614	US10077269, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 84::US10669279, Example 84	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 7.84							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875397	378169253							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579201	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2	LLKDXLOAXVIBRW-UHFFFAOYSA-N	285614	US10077269, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 84::US10669279, Example 84	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 44.4							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875397	378169253							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579202	Clc1cccc(c1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C16H13ClN4O/c17-12-5-1-4-11(10-12)15-14(16(22)20-8-3-9-20)19-13-6-2-7-18-21(13)15/h1-2,4-7,10H,3,8-9H2	LLKDXLOAXVIBRW-UHFFFAOYSA-N	285614	US10077269, Example 84::azetidin-1-yl[3-(3-chloro-phenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 84::US10669279, Example 84	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 977							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285614	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285614&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875397	378169253							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579203	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21)	SNPDIBMAAUTAIH-UHFFFAOYSA-N	285615	US10077269, Example 85::3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 85::US10669279, Example 85	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 25.6							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875373	378169254							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579204	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21)	SNPDIBMAAUTAIH-UHFFFAOYSA-N	285615	US10077269, Example 85::3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 85::US10669279, Example 85	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 87.3							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875373	378169254							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579205	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21)	SNPDIBMAAUTAIH-UHFFFAOYSA-N	285615	US10077269, Example 85::3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 85::US10669279, Example 85	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 47.2							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875373	378169254							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579206	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1	InChI=1S/C15H13ClN4O/c1-2-17-15(21)13-14(10-5-7-11(16)8-6-10)20-12(19-13)4-3-9-18-20/h3-9H,2H2,1H3,(H,17,21)	SNPDIBMAAUTAIH-UHFFFAOYSA-N	285615	US10077269, Example 85::3-(4-chlorophenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 85::US10669279, Example 85	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 6700							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285615	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285615&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875373	378169254							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579207	FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2	CIMWFDZKHUKERW-UHFFFAOYSA-N	285616	US10077269, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 86::US10669279, Example 86	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 5.83							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875409	378169255							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579208	FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2	CIMWFDZKHUKERW-UHFFFAOYSA-N	285616	US10077269, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 86::US10669279, Example 86	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 7.72							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875409	378169255							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579209	FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2	CIMWFDZKHUKERW-UHFFFAOYSA-N	285616	US10077269, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 86::US10669279, Example 86	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 25.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875409	378169255							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579210	FC1(F)Oc2ccc(cc2O1)-c1c(nc2cccnn12)C(=O)N1CCC1	InChI=1S/C17H12F2N4O3/c18-17(19)25-11-5-4-10(9-12(11)26-17)15-14(16(24)22-7-2-8-22)21-13-3-1-6-20-23(13)15/h1,3-6,9H,2,7-8H2	CIMWFDZKHUKERW-UHFFFAOYSA-N	285616	US10077269, Example 86::azetidin-1-yl[3-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 86::US10669279, Example 86	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 179							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285616	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285616&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875409	378169255							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579211	FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24)	YCEYKGZVRQVUNW-UHFFFAOYSA-N	285617	US10077269, Example 87::N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 87::US10669279, Example 87	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 240							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875385	378169256							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579212	FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24)	YCEYKGZVRQVUNW-UHFFFAOYSA-N	285617	US10077269, Example 87::N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 87::US10669279, Example 87	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 173							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875385	378169256							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579213	FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24)	YCEYKGZVRQVUNW-UHFFFAOYSA-N	285617	US10077269, Example 87::N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 87::US10669279, Example 87	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 397							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875385	378169256							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579214	FC(F)Oc1ccc(cn1)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H13F2N5O2/c17-16(18)25-12-6-3-9(8-19-12)14-13(15(24)21-10-4-5-10)22-11-2-1-7-20-23(11)14/h1-3,6-8,10,16H,4-5H2,(H,21,24)	YCEYKGZVRQVUNW-UHFFFAOYSA-N	285617	US10077269, Example 87::N-cyclopropyl-3-[6-(difluoromethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 87::US10669279, Example 87	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 6790							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285617	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285617&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875385	378169256							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579215	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23)	QCUHKLBHHWHXAM-UHFFFAOYSA-N	285618	US10077269, Example 88::3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 88::US10669279, Example 88	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 45.0							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700202	378169257							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579216	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23)	QCUHKLBHHWHXAM-UHFFFAOYSA-N	285618	US10077269, Example 88::3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 88::US10669279, Example 88	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 39.2							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700202	378169257							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579217	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23)	QCUHKLBHHWHXAM-UHFFFAOYSA-N	285618	US10077269, Example 88::3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 88::US10669279, Example 88	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 136							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700202	378169257							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579218	O=C(NC1CC1)c1nc2cccnn2c1-c1ccc2ncoc2c1	InChI=1S/C17H13N5O2/c23-17(20-11-4-5-11)15-16(22-14(21-15)2-1-7-19-22)10-3-6-12-13(8-10)24-9-18-12/h1-3,6-9,11H,4-5H2,(H,20,23)	QCUHKLBHHWHXAM-UHFFFAOYSA-N	285618	US10077269, Example 88::3-(1,3-benzoxazol-6-yl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 88::US10669279, Example 88	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 10400							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285618	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285618&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700202	378169257							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579219	Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(-3.16,.94,;-1.67,1.33,;-1.27,2.82,;.22,3.22,;.92,4.59,;2.44,4.35,;2.68,2.83,;1.31,2.13,;.91,.64,;-.58,.24,;-.98,-1.24,;-.07,-2.49,;-.98,-3.73,;-2.44,-3.26,;-3.78,-4.03,;-5.11,-3.26,;-5.11,-1.72,;-3.78,-.95,;-2.44,-1.72,;1.47,-2.49,;2.24,-1.15,;2.24,-3.82,;3.78,-3.82,;5.11,-4.59,;5.11,-3.05,)|	InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25)	HWZASUIHFDZUSF-UHFFFAOYSA-N	285619	US10077269, Example 89::N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 89::US10669279, Example 89	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 829							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875367	378169258							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579220	Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(-3.16,.94,;-1.67,1.33,;-1.27,2.82,;.22,3.22,;.92,4.59,;2.44,4.35,;2.68,2.83,;1.31,2.13,;.91,.64,;-.58,.24,;-.98,-1.24,;-.07,-2.49,;-.98,-3.73,;-2.44,-3.26,;-3.78,-4.03,;-5.11,-3.26,;-5.11,-1.72,;-3.78,-.95,;-2.44,-1.72,;1.47,-2.49,;2.24,-1.15,;2.24,-3.82,;3.78,-3.82,;5.11,-4.59,;5.11,-3.05,)|	InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25)	HWZASUIHFDZUSF-UHFFFAOYSA-N	285619	US10077269, Example 89::N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 89::US10669279, Example 89	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 333							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875367	378169258							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579221	Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(-3.16,.94,;-1.67,1.33,;-1.27,2.82,;.22,3.22,;.92,4.59,;2.44,4.35,;2.68,2.83,;1.31,2.13,;.91,.64,;-.58,.24,;-.98,-1.24,;-.07,-2.49,;-.98,-3.73,;-2.44,-3.26,;-3.78,-4.03,;-5.11,-3.26,;-5.11,-1.72,;-3.78,-.95,;-2.44,-1.72,;1.47,-2.49,;2.24,-1.15,;2.24,-3.82,;3.78,-3.82,;5.11,-4.59,;5.11,-3.05,)|	InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25)	HWZASUIHFDZUSF-UHFFFAOYSA-N	285619	US10077269, Example 89::N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 89::US10669279, Example 89	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 3760							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875367	378169258							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579222	Cc1cc2ncnn2cc1-c1c(nc2cccnn12)C(=O)NC1CC1 |(-3.16,.94,;-1.67,1.33,;-1.27,2.82,;.22,3.22,;.92,4.59,;2.44,4.35,;2.68,2.83,;1.31,2.13,;.91,.64,;-.58,.24,;-.98,-1.24,;-.07,-2.49,;-.98,-3.73,;-2.44,-3.26,;-3.78,-4.03,;-5.11,-3.26,;-5.11,-1.72,;-3.78,-.95,;-2.44,-1.72,;1.47,-2.49,;2.24,-1.15,;2.24,-3.82,;3.78,-3.82,;5.11,-4.59,;5.11,-3.05,)|	InChI=1S/C17H15N7O/c1-10-7-14-18-9-20-23(14)8-12(10)16-15(17(25)21-11-4-5-11)22-13-3-2-6-19-24(13)16/h2-3,6-9,11H,4-5H2,1H3,(H,21,25)	HWZASUIHFDZUSF-UHFFFAOYSA-N	285619	US10077269, Example 89::N-cyclopropyl-3-(7-methyl[1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 89::US10669279, Example 89	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>17200							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285619	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285619&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875367	378169258							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579223	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24)	VOILLODEUKMPEX-UHFFFAOYSA-N	285620	US10077269, Example 90::3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 90::US10669279, Example 90	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 21.4							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875402	378169259							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579224	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24)	VOILLODEUKMPEX-UHFFFAOYSA-N	285620	US10077269, Example 90::3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 90::US10669279, Example 90	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 43.7							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875402	378169259							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579225	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24)	VOILLODEUKMPEX-UHFFFAOYSA-N	285620	US10077269, Example 90::3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 90::US10669279, Example 90	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 25.5							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875402	378169259							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579226	Fc1cc(ccc1C#N)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C17H12FN5O/c18-13-8-10(3-4-11(13)9-19)16-15(17(24)21-12-5-6-12)22-14-2-1-7-20-23(14)16/h1-4,7-8,12H,5-6H2,(H,21,24)	VOILLODEUKMPEX-UHFFFAOYSA-N	285620	US10077269, Example 90::3-(4-cyano-3-fluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 90::US10669279, Example 90	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2620							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285620	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285620&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875402	378169259							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579227	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl |(3.49,3.03,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,;-.98,1.83,;-2.46,1.44,;-.58,3.32,;.91,3.72,;1.31,5.21,)|	InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2	PAISFAPTLJTHAX-UHFFFAOYSA-N	285621	US10077269, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 91::US10669279, Example 91	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 12.6							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700204	378169260							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579228	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl |(3.49,3.03,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,;-.98,1.83,;-2.46,1.44,;-.58,3.32,;.91,3.72,;1.31,5.21,)|	InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2	PAISFAPTLJTHAX-UHFFFAOYSA-N	285621	US10077269, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 91::US10669279, Example 91	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 36.9							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700204	378169260							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579229	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl |(3.49,3.03,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,;-.98,1.83,;-2.46,1.44,;-.58,3.32,;.91,3.72,;1.31,5.21,)|	InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2	PAISFAPTLJTHAX-UHFFFAOYSA-N	285621	US10077269, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 91::US10669279, Example 91	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 80.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700204	378169260							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579230	Fc1cc(-c2c(nc3cccnn23)C(=O)N2CCC2)c(F)cc1Cl |(3.49,3.03,;2,2.63,;1.6,1.14,;.11,.75,;-.29,-.74,;.62,-1.99,;-.29,-3.23,;-1.75,-2.76,;-3.08,-3.53,;-4.42,-2.76,;-4.42,-1.22,;-3.08,-.45,;-1.75,-1.22,;2.16,-1.99,;2.93,-.65,;2.93,-3.32,;2.53,-4.81,;4.02,-5.21,;4.42,-3.72,;-.98,1.83,;-2.46,1.44,;-.58,3.32,;.91,3.72,;1.31,5.21,)|	InChI=1S/C16H11ClF2N4O/c17-10-8-11(18)9(7-12(10)19)15-14(16(24)22-5-2-6-22)21-13-3-1-4-20-23(13)15/h1,3-4,7-8H,2,5-6H2	PAISFAPTLJTHAX-UHFFFAOYSA-N	285621	US10077269, Example 91::azetidin-1-yl[3-(4-chloro-2,5-difluorophenyl)imidazo[1,2-b]pyridazin-2-yl]methanone::US9598421, Example 91::US10669279, Example 91	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 2250							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285621	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285621&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700204	378169260							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579231	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N |(2.79,1.73,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;-1.67,.53,;-3.16,.13,;-1.27,2.02,;.21,2.51,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25)	RESYBSJMKXZFCE-UHFFFAOYSA-N	285622	US10077269, Example 92::3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 92::US10669279, Example 92	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 5.52							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875378	378169261							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579232	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N |(2.79,1.73,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;-1.67,.53,;-3.16,.13,;-1.27,2.02,;.21,2.51,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25)	RESYBSJMKXZFCE-UHFFFAOYSA-N	285622	US10077269, Example 92::3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 92::US10669279, Example 92	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 21.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875378	378169261							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579233	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N |(2.79,1.73,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;-1.67,.53,;-3.16,.13,;-1.27,2.02,;.21,2.51,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25)	RESYBSJMKXZFCE-UHFFFAOYSA-N	285622	US10077269, Example 92::3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 92::US10669279, Example 92	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 42.5							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875378	378169261							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579234	Fc1cc(-c2c(nc3cccnn23)C(=O)NC2CC2)c(F)cc1C#N |(2.79,1.73,;1.31,1.33,;.91,-.16,;-.58,-.56,;-.98,-2.04,;-.07,-3.29,;-.98,-4.54,;-2.44,-4.06,;-3.78,-4.83,;-5.11,-4.06,;-5.11,-2.52,;-3.78,-1.75,;-2.44,-2.52,;1.47,-3.29,;2.24,-1.96,;2.24,-4.62,;3.78,-4.62,;5.11,-5.39,;5.11,-3.85,;-1.67,.53,;-3.16,.13,;-1.27,2.02,;.21,2.51,;.59,4.01,;.97,5.5,)|	InChI=1S/C17H11F2N5O/c18-12-7-11(13(19)6-9(12)8-20)16-15(17(25)22-10-3-4-10)23-14-2-1-5-21-24(14)16/h1-2,5-7,10H,3-4H2,(H,22,25)	RESYBSJMKXZFCE-UHFFFAOYSA-N	285622	US10077269, Example 92::3-(4-cyano-2,5-difluorophenyl)-N-cyclopropylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 92::US10669279, Example 92	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>1440							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285622	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285622&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875378	378169261							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579235	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.44,-4.16,;2.9,-4.16,;2.13,-2.83,;2.9,-1.49,;.59,-2.83,;-.31,-4.07,;-1.78,-3.6,;-3.11,-4.37,;-4.44,-3.6,;-4.44,-2.06,;-3.11,-1.29,;-1.78,-2.06,;-.31,-1.58,;.09,-.09,;1.57,.3,;1.97,1.79,;3.46,2.19,;.88,2.88,;1.28,4.37,;-.6,2.48,;-1,.99,;-2.49,.6,)|	InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22)	LVRAFMJECWTOEO-UHFFFAOYSA-N	285623	US10077269, Example 93::3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 93::US10669279, Example 93	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 62.9							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875371	378169262							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579236	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.44,-4.16,;2.9,-4.16,;2.13,-2.83,;2.9,-1.49,;.59,-2.83,;-.31,-4.07,;-1.78,-3.6,;-3.11,-4.37,;-4.44,-3.6,;-4.44,-2.06,;-3.11,-1.29,;-1.78,-2.06,;-.31,-1.58,;.09,-.09,;1.57,.3,;1.97,1.79,;3.46,2.19,;.88,2.88,;1.28,4.37,;-.6,2.48,;-1,.99,;-2.49,.6,)|	InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22)	LVRAFMJECWTOEO-UHFFFAOYSA-N	285623	US10077269, Example 93::3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 93::US10669279, Example 93	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 276							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875371	378169262							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579237	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.44,-4.16,;2.9,-4.16,;2.13,-2.83,;2.9,-1.49,;.59,-2.83,;-.31,-4.07,;-1.78,-3.6,;-3.11,-4.37,;-4.44,-3.6,;-4.44,-2.06,;-3.11,-1.29,;-1.78,-2.06,;-.31,-1.58,;.09,-.09,;1.57,.3,;1.97,1.79,;3.46,2.19,;.88,2.88,;1.28,4.37,;-.6,2.48,;-1,.99,;-2.49,.6,)|	InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22)	LVRAFMJECWTOEO-UHFFFAOYSA-N	285623	US10077269, Example 93::3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 93::US10669279, Example 93	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 134							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875371	378169262							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579238	CNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.44,-4.16,;2.9,-4.16,;2.13,-2.83,;2.9,-1.49,;.59,-2.83,;-.31,-4.07,;-1.78,-3.6,;-3.11,-4.37,;-4.44,-3.6,;-4.44,-2.06,;-3.11,-1.29,;-1.78,-2.06,;-.31,-1.58,;.09,-.09,;1.57,.3,;1.97,1.79,;3.46,2.19,;.88,2.88,;1.28,4.37,;-.6,2.48,;-1,.99,;-2.49,.6,)|	InChI=1S/C14H9ClF2N4O/c1-18-14(22)12-13(21-11(20-12)3-2-4-19-21)7-5-10(17)8(15)6-9(7)16/h2-6H,1H3,(H,18,22)	LVRAFMJECWTOEO-UHFFFAOYSA-N	285623	US10077269, Example 93::3-(4-chloro-2,5-difluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 93::US10669279, Example 93	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 4110							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285623	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285623&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875371	378169262							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579239	CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21)	XVPMLCYXSAROSC-UHFFFAOYSA-N	285624	US10077269, Example 94::3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 94::US10669279, Example 94	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 24.9							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875407	378169263							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579240	CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21)	XVPMLCYXSAROSC-UHFFFAOYSA-N	285624	US10077269, Example 94::3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 94::US10669279, Example 94	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 253							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875407	378169263							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579241	CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21)	XVPMLCYXSAROSC-UHFFFAOYSA-N	285624	US10077269, Example 94::3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 94::US10669279, Example 94	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 65.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875407	378169263							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579242	CNC(=O)c1nc2cccnn2c1-c1ccc(Cl)c(F)c1	InChI=1S/C14H10ClFN4O/c1-17-14(21)12-13(8-4-5-9(15)10(16)7-8)20-11(19-12)3-2-6-18-20/h2-7H,1H3,(H,17,21)	XVPMLCYXSAROSC-UHFFFAOYSA-N	285624	US10077269, Example 94::3-(4-chloro-3-fluorophenyl)-N-methylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 94::US10669279, Example 94	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 5380							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285624	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285624&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875407	378169263							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579243	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1C |(4.83,-4.93,;4.06,-3.6,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C16H15ClN4O/c1-3-18-16(22)14-15(12-7-6-11(17)9-10(12)2)21-13(20-14)5-4-8-19-21/h4-9H,3H2,1-2H3,(H,18,22)	HRLMOSFOSQNGMI-UHFFFAOYSA-N	285625	US10077269, Example 95::3-(4-chloro-2-methylphenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 95::US10669279, Example 95	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 306							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285625	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285625&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875368	378169264							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579244	CCNC(=O)c1nc2cccnn2c1-c1ccc(Cl)cc1C |(4.83,-4.93,;4.06,-3.6,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C16H15ClN4O/c1-3-18-16(22)14-15(12-7-6-11(17)9-10(12)2)21-13(20-14)5-4-8-19-21/h4-9H,3H2,1-2H3,(H,18,22)	HRLMOSFOSQNGMI-UHFFFAOYSA-N	285625	US10077269, Example 95::3-(4-chloro-2-methylphenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 95::US10669279, Example 95	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 14800							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285625	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285625&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875368	378169264							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579245	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.83,-4.93,;4.06,-3.6,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23)	IMOBPVDSTURWHO-UHFFFAOYSA-N	285626	US10077269, Example 96::3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 96::US10669279, Example 96	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 4.58							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875399	378169265							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579246	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.83,-4.93,;4.06,-3.6,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23)	IMOBPVDSTURWHO-UHFFFAOYSA-N	285626	US10077269, Example 96::3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 96::US10669279, Example 96	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 33.2							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875399	378169265							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579247	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.83,-4.93,;4.06,-3.6,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23)	IMOBPVDSTURWHO-UHFFFAOYSA-N	285626	US10077269, Example 96::3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 96::US10669279, Example 96	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 29.2							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875399	378169265							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579248	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.83,-4.93,;4.06,-3.6,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C15H11ClF2N4O/c1-2-19-15(23)13-14(22-12(21-13)4-3-5-20-22)8-6-11(18)9(16)7-10(8)17/h3-7H,2H2,1H3,(H,19,23)	IMOBPVDSTURWHO-UHFFFAOYSA-N	285626	US10077269, Example 96::3-(4-chloro-2,5-difluoro-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 96::US10669279, Example 96	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 908							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285626	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285626&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875399	378169265							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579249	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C |(4.83,-2.26,;4.06,-3.6,;4.83,-4.93,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24)	VJEYWPJLEFUOTH-UHFFFAOYSA-N	285627	US10077269, Example 97::3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 97::US10669279, Example 97	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 5.48							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700205	378169266							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579250	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C |(4.83,-2.26,;4.06,-3.6,;4.83,-4.93,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24)	VJEYWPJLEFUOTH-UHFFFAOYSA-N	285627	US10077269, Example 97::3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 97::US10669279, Example 97	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 23.3							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700205	378169266							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579251	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C |(4.83,-2.26,;4.06,-3.6,;4.83,-4.93,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24)	VJEYWPJLEFUOTH-UHFFFAOYSA-N	285627	US10077269, Example 97::3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 97::US10669279, Example 97	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 20.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700205	378169266							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579252	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1C |(4.83,-2.26,;4.06,-3.6,;4.83,-4.93,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C17H16ClFN4O/c1-9(2)21-17(24)15-16(23-14(22-15)5-4-6-20-23)11-8-13(19)12(18)7-10(11)3/h4-9H,1-3H3,(H,21,24)	VJEYWPJLEFUOTH-UHFFFAOYSA-N	285627	US10077269, Example 97::3-(4-chloro-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 97::US10669279, Example 97	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>1850							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285627	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285627&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700205	378169266							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579253	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24)	FKAXUOKPFFFYTF-UHFFFAOYSA-N	285628	US10077269, Example 98::3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 98::US10669279, Example 98	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 26.6							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700206	378169267							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579254	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24)	FKAXUOKPFFFYTF-UHFFFAOYSA-N	285628	US10077269, Example 98::3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 98::US10669279, Example 98	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 62.7							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700206	378169267							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579255	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24)	FKAXUOKPFFFYTF-UHFFFAOYSA-N	285628	US10077269, Example 98::3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 98::US10669279, Example 98	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 107							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700206	378169267							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579256	CCNC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C17H14FN5O/c1-3-20-17(24)15-16(23-14(22-15)5-4-6-21-23)12-8-13(18)11(9-19)7-10(12)2/h4-8H,3H2,1-2H3,(H,20,24)	FKAXUOKPFFFYTF-UHFFFAOYSA-N	285628	US10077269, Example 98::3-(4-cyano-5-fluoro-2-methyl-phenyl)-N-ethylimidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 98::US10669279, Example 98	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 3320							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285628	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285628&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700206	378169267							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579257	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;4.83,-3.01,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25)	LCTMXACJLVAYNA-UHFFFAOYSA-N	285629	US10077269, Example 99::3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 99::US10669279, Example 99	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 19.8							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875366	378169268							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579258	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;4.83,-3.01,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25)	LCTMXACJLVAYNA-UHFFFAOYSA-N	285629	US10077269, Example 99::3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 99::US10669279, Example 99	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 36.2							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875366	378169268							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579259	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;4.83,-3.01,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25)	LCTMXACJLVAYNA-UHFFFAOYSA-N	285629	US10077269, Example 99::3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 99::US10669279, Example 99	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 138							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875366	378169268							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579260	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(cc1C)C#N |(4.83,-5.68,;4.06,-4.34,;4.83,-3.01,;2.52,-4.34,;1.75,-3.01,;2.52,-1.67,;.21,-3.01,;-.7,-4.25,;-2.16,-3.78,;-3.49,-4.55,;-4.83,-3.78,;-4.83,-2.24,;-3.49,-1.47,;-2.16,-2.24,;-.7,-1.76,;-.3,-.27,;1.19,.12,;1.59,1.61,;3.08,2.01,;.49,2.8,;-.99,2.3,;-1.39,.81,;-2.87,.42,;.87,4.29,;1.25,5.78,)|	InChI=1S/C18H16FN5O/c1-10(2)22-18(25)16-17(24-15(23-16)5-4-6-21-24)13-8-14(19)12(9-20)7-11(13)3/h4-8,10H,1-3H3,(H,22,25)	LCTMXACJLVAYNA-UHFFFAOYSA-N	285629	US10077269, Example 99::3-(4-cyano-5-fluoro-2-methylphenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 99::US10669279, Example 99	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 1550							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285629	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285629&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875366	378169268							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579261	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.83,-4.93,;4.06,-3.6,;4.83,-2.26,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C16H13ClF2N4O/c1-8(2)21-16(24)14-15(23-13(22-14)4-3-5-20-23)9-6-12(19)10(17)7-11(9)18/h3-8H,1-2H3,(H,21,24)	JMTGAAJHYHUEQI-UHFFFAOYSA-N	285630	US10077269, Example 100::3-(4-chloro-2,5-difluoro-phenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 100::US10669279, Example 100	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 49.1							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285630	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285630&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700207	378169269							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579262	CC(C)NC(=O)c1nc2cccnn2c1-c1cc(F)c(Cl)cc1F |(4.83,-4.93,;4.06,-3.6,;4.83,-2.26,;2.52,-3.6,;1.75,-2.26,;2.52,-.93,;.21,-2.26,;-.7,-3.51,;-2.16,-3.03,;-3.49,-3.8,;-4.83,-3.03,;-4.83,-1.49,;-3.49,-.72,;-2.16,-1.49,;-.7,-1.02,;-.3,.47,;1.19,.87,;1.59,2.36,;3.08,2.75,;.5,3.44,;.9,4.93,;-.99,3.05,;-1.39,1.56,;-2.87,1.16,)|	InChI=1S/C16H13ClF2N4O/c1-8(2)21-16(24)14-15(23-13(22-14)4-3-5-20-23)9-6-12(19)10(17)7-11(9)18/h3-8H,1-2H3,(H,21,24)	JMTGAAJHYHUEQI-UHFFFAOYSA-N	285630	US10077269, Example 100::3-(4-chloro-2,5-difluoro-phenyl)-N-(propan-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 100::US10669279, Example 100	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 766							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285630	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285630&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700207	378169269							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579263	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1	InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25)	LHIGSNUVLANYIO-UHFFFAOYSA-N	285631	US10077269, Example 101::3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 101::US10669279, Example 101	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 268							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875390	378169270							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579264	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1	InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25)	LHIGSNUVLANYIO-UHFFFAOYSA-N	285631	US10077269, Example 101::3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 101::US10669279, Example 101	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 861							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875390	378169270							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579265	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1	InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25)	LHIGSNUVLANYIO-UHFFFAOYSA-N	285631	US10077269, Example 101::3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 101::US10669279, Example 101	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 1179							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875390	378169270							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579266	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ncccn1	InChI=1S/C17H11ClN6O/c18-12-6-4-11(5-7-12)15-14(22-13-3-1-10-21-24(13)15)16(25)23-17-19-8-2-9-20-17/h1-10H,(H,19,20,23,25)	LHIGSNUVLANYIO-UHFFFAOYSA-N	285631	US10077269, Example 101::3-(4-chlorophenyl)-N-(pyrimidin-2-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 101::US10669279, Example 101	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		>25900							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285631	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285631&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875390	378169270							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579267	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23)	VFBYVKMGLDMLTI-UHFFFAOYSA-N	285632	US10077269, Example 102::3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 102::US10669279, Example 102	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 59.9							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126700208	378169271							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579268	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23)	VFBYVKMGLDMLTI-UHFFFAOYSA-N	285632	US10077269, Example 102::3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 102::US10669279, Example 102	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 103							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126700208	378169271							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579269	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23)	VFBYVKMGLDMLTI-UHFFFAOYSA-N	285632	US10077269, Example 102::3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 102::US10669279, Example 102	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 76.0							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126700208	378169271							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579270	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)NCC1CC1	InChI=1S/C17H15ClN4O/c18-13-7-5-12(6-8-13)16-15(17(23)19-10-11-3-4-11)21-14-2-1-9-20-22(14)16/h1-2,5-9,11H,3-4,10H2,(H,19,23)	VFBYVKMGLDMLTI-UHFFFAOYSA-N	285632	US10077269, Example 102::3-(4-chlorophenyl)-N-(cyclo-propylmethyl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 102::US10669279, Example 102	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 5010							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285632	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285632&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126700208	378169271							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579271	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1	InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24)	XMHPQZNHOIRAHG-UHFFFAOYSA-N	285633	US10077269, Example 103::3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 103::US10669279, Example 103	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		 62.7							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			126703955	378169272							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579272	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1	InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24)	XMHPQZNHOIRAHG-UHFFFAOYSA-N	285633	US10077269, Example 103::3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 103::US10669279, Example 103	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 249							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			126703955	378169272							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579273	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1	InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24)	XMHPQZNHOIRAHG-UHFFFAOYSA-N	285633	US10077269, Example 103::3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 103::US10669279, Example 103	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 203							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			126703955	378169272							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579274	Clc1ccc(cc1)-c1c(nc2cccnn12)C(=O)Nc1ccn[nH]1	InChI=1S/C16H11ClN6O/c17-11-5-3-10(4-6-11)15-14(16(24)20-12-7-9-18-22-12)21-13-2-1-8-19-23(13)15/h1-9H,(H2,18,20,22,24)	XMHPQZNHOIRAHG-UHFFFAOYSA-N	285633	US10077269, Example 103::3-(4-chlorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 103::US10669279, Example 103	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 1550							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285633	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285633&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			126703955	378169272							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579275	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24)	GYZISZRYVGZYRR-UHFFFAOYSA-N	285634	US10077269, Example 104::3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 104::US10669279, Example 104	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Human		<0.488							US Patent		10.7270/Q2K939KG		aid1796120	US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=1180&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4A&column=ki&startPg=0&Increment=50&submit=Search			118875388	378169273							1	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT	3TVX,2QYK,3I8V	3',5'-cyclic-AMP phosphodiesterase 4A	PDE4A_HUMAN	P27815	O75522 O76092 Q16255 Q16691 Q5DM53 Q6PMT2 Q8IVA7 Q8WUQ3 Q9H3H2																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579276	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24)	GYZISZRYVGZYRR-UHFFFAOYSA-N	285634	US10077269, Example 104::3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 104::US10669279, Example 104	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Human		 1.59							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=362&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4B&column=ki&startPg=0&Increment=50&submit=Search			118875388	378169273							1	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQSERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVLHATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVRNNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYRSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKKKQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSHNRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHVLLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTSSGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSPSPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLGETDIDIATEDKSPVDT	3WD9,3W5E,1TB5,4NW7,4MYQ,2QYL,4KP6,5K6J,3O0J,7B9H,7AY6,6FDC,6F8X,6F8W,6F8V,6F8U,6F8T,6F8R,6F6U	3',5'-cyclic-AMP phosphodiesterase 4B	PDE4B_HUMAN	Q07343	A5YW33 O15443 Q13945 Q5TEK4 Q5TEK5 Q5TEK6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579277	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24)	GYZISZRYVGZYRR-UHFFFAOYSA-N	285634	US10077269, Example 104::3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 104::US10669279, Example 104	cAMP-specific 3',5'-cyclic phosphodiesterase 4C	Human		 4.69							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=716&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4C&column=ki&startPg=0&Increment=50&submit=Search			118875388	378169273							1	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDPDKSAGCRERDLSPRPELRKSRLSWPVSSCRRFDLENGLSCGRRALDPQSSPGLGRIMQAPVPHSQRRESFLYRSDSDYELSPKAMSRNSSVASDLHGEDMIVTPFAQVLASLRTVRSNVAALARQQCLGAAKQGPVGNPSSSNQLPPAEDTGQKLALETLDELDWCLDQLETLQTRHSVGEMASNKFKRILNRELTHLSETSRSGNQVSEYISRTFLDQQTEVELPKVTAEEAPQPMSRISGLHGLCHSASLSSATVPRFGVQTDQEEQLAKELEDTNKWGLDVFKVAELSGNRPLTAIIFSIFQERDLLKTFQIPADTLATYLLMLEGHYHANVAYHNSLHAADVAQSTHVLLATPALEAVFTDLEILAALFASAIHDVDHPGVSNQFLINTNSELALMYNDASVLENHHLAVGFKLLQAENCDIFQNLSAKQRLSLRRMVIDMVLATDMSKHMNLLADLKTMVETKKVTSLGVLLLDNYSDRIQVLQNLVHCADLSNPTKPLPLYRQWTDRIMAEFFQQGDRERESGLDISPMCDKHTASVEKSQVGFIDYIAHPLWETWADLVHPDAQDLLDTLEDNREWYQSKIPRSPSDLTNPERDGPDRFQFELTLEEAEEEDEEEEEEGEETALAKEALELPDTELLSPEAGPDPGDLPLDNQRT	2QYM,2PW3,5K32	3',5'-cyclic-AMP phosphodiesterase 4C	PDE4C_HUMAN	Q08493	B3KTC4 Q9UN44 Q9UN45 Q9UN46 Q9UPJ6																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
579278	Fc1cc(cc(F)c1Cl)-c1c(nc2cccnn12)C(=O)NC1CC1	InChI=1S/C16H11ClF2N4O/c17-13-10(18)6-8(7-11(13)19)15-14(16(24)21-9-3-4-9)22-12-2-1-5-20-23(12)15/h1-2,5-7,9H,3-4H2,(H,21,24)	GYZISZRYVGZYRR-UHFFFAOYSA-N	285634	US10077269, Example 104::3-(4-chloro-3,5-difluoro-phenyl)-N-cyclopropyl-imidazo[1,2-b]pyridazine-2-carboxamide::US9598421, Example 104::US10669279, Example 104	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Human		 145							US Patent		10.7270/Q2K939KG			US9598421	Chappie, TA; Verhoest, PR; Patel, NC; Hayward, MM; Helal, CJ; Sciabola, S; LaChapelle, EA; Young, JM	3/21/2017	3/29/2019	Pfizer	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=285634	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6551&target=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=285634&enzyme=cAMP-specific+3%27%2C5%27-cyclic+phosphodiesterase+4D&column=ki&startPg=0&Increment=50&submit=Search			118875388	378169273							1	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPPPPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNFAALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT	7XBB,7XAB,7XAA,7F2M,7F2L,7F2K,5WH6,9LO7,8ZQW,8ZQU,8ZQ2,8ZQ1,8YLC,4OGB,3SL8,3SL6,3SL4,3SL3,2FM5,2FM0,3V9B,1Q9M,1PTW,1OYN,7ABJ,7ABE,7ABD,7AB9,7AAG,7A9V,7A8Q,6RCW,6IBF,6IAG,6HWO,6FW3,6FTW,6FTA,6FT0,6FET,6FEB,6FE7,6FDI,6AKR,5LBO,4WCU,4W1O,6ZBA,8XXS,5WQA,1ZKN,6KJZ,1TBB,1TB7,2QYN,5WH5,6KK0,5K1I,5K32,5K6J,3O0J	3',5'-cyclic-AMP phosphodiesterase 4D	PDE4D_HUMAN	Q08499	O43433 Q13549 Q13550 Q13551 Q7Z2L8 Q8IV84 Q8IVA9 Q8IVD2 Q8IVD3 Q96HL4 Q9HCX7